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Brown adipose tissue
Brown adipose tissue (BAT) has been known since 1551 when the Swiss biologist 
Conrad Gesner described the observation of a body part in marmots he defined as 
“neither fat, nor flesh; nec pinguitudo, nec caro” (Figure 1).1,2 This description then 
already assumed that BAT was different from white adipose tissue (WAT) based on 
its macroscopic appearance. Throughout the centuries more knowledge has been 
obtained on BAT and in 1972 a detailed anatomical description of BAT in man was 
published.3 The brown adipocyte (fat cell) contains multiple fat vacuoles and a 
granular cytoplasm consisting of a large number of mitochondria which gives it its 
brown appearance.3 Except from colour (which varies from caramel-coloured - to 
brown - to dark red), BAT is highly vascularized, sympathetically innervated and 
most importantly functionally different from WAT; animal studies have confirmed 
that the primary function of BAT is heat production upon cold exposure and diet, 
in contrast to WAT that mainly serves energy storage.4,5 
Function of brown adipose tissue 
When exposed to a cold environment, the heat production in BAT serves an important 
function in small animals and human newborns by preventing hypothermia.5 This 
heat production during cold exposure is defined as non-shivering thermogenesis 
(NST), in contrast to shivering thermogenesis (ST) resulting from skeletal muscle 
contractions.6 NST in BAT is suggested to be responsible for an increase in energy 
expenditure of ~50% in mice.5,7 In addition to NST, BAT has been shown to become 
active in rodents after overeating (facultative diet-induced thermogenesis; fDIT). 
The function of fDIT is to decrease metabolic efficiency and prevent obesity, 
although this is disputed by others.8,9 Genetically modified mice without functional 
BAT become obese and develop obesity-related comorbidities, suggesting BAT is 
important in weight management.7 This indicates that BAT is an important organ 
with a vital role in maintaining the energy balance, at least in mice. BAT produces 
heat by the activity of uncoupling protein 1 (UCP1), first described in 1978.10 UCP1 
is located on the inner mitochondrial membrane of the brown adipocyte and is 
capable of producing heat.5,11 In the majority of the cells in the human body, the 
mitochondrial proton gradient is designed to produce adenosine-triphosphate (ATP), 
the key energy carrier in all of the human body’s metabolic processes. However, in 
BAT the unique presence of UCP1 facilitates proton leakage over the mitochondrial 
inner-membrane and thus heat production instead of ATP generation.
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Figure 1. Front of Conrad Gesner’s Historiae Animalum, with underlined detail of the first description of 
brown adipose tissue; “nec pinguitido, nec caro”, neither fat nor flesh. Figure obtained from Google Books, with 
special thanks to prof. Jan Nedergaard.
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Rediscovery of functional brown adipose tissue in adult humans
In human neonates, BAT is found in the neck along the greater vessels and 
muscles, supraclavicular and interscapular area, mediastinum and around the 
aorta, pancreas, spleen, kidneys and suprarenal glands.3 The total weight of BAT 
(~150-250 g) in newborns consists of 2-5% of the body’s total amount of adipose 
tissue.4 BAT in adults was known for several decades, but it has only recently 
been shown that adult humans possess significant amounts of physiological 
active BAT. In 1985 Astrup et al. performed dedicated studies on human BAT 
and measured temperatures in interscapular and perirenal BAT before and after 
stimulation with the sympathomimetic ephedrine.12,13 Although thermogenesis 
increased significantly, unfortunately no contribution of BAT could be found.12,13 
In the last decade, the evolvement of new imaging techniques made it possible to 
determine the functionality of human BAT. The development of positron-emission-
tomography-and-computed-tomography (PET-CT), where the radioactive glucose 
tracer 2-deoxy-2-18F-fluoro-D-glucose (FDG) shows cellular glucose uptake, 
gives the opportunity to depict metabolically active tissues. FDG-PET-CT studies 
are clinically widely used in oncological imaging. Interestingly, it was frequently 
observed that FDG uptake occurred in adipose tissue (Figure 2),14 located in 
anatomical areas that were described in anatomical studies earlier to contain BAT.3 
This FDG-PET-CT-positive adipose tissue was mostly observed in patients feeling 
cold and repeated scanning under warm conditions prevented the uptake in those 
areas (Figure 3).15,16 This raised scientific interest  from autopsies.17 Moreover, there 
was a significant negative correlation between the amount of active BAT and the 
Figure 2. FDG-PET-CT-image of a female patient with non-small-cell lung cancer (NSCLC) showing increased 
FDG-uptake in periclavicular and paravertebral adipose tissue during uncontrolled conditions (A) and absence 
of FDG-uptake in adipose tissue during warm conditions (B; room temperature 22-25° Celsius). Image ob-
tained from Christensen et al.15
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percentage of body fat and BMI, i.e. a low BAT activity in obesity (Figure 4).17 
and a prospective study from our research group in young, healthy subjects under 
controlled mild cold exposure showed active BAT in the majority of the study group 
(96%) in anatomical regions similar to descriptive observations. Adipose tissue 
biopsies taken from the regions that showed FDG-uptake on PET-CT during cold 
exposure confirmed the histological presence of brown adipocytes (Figure 5).17,18 
Retrospective analyses of cohorts of clinically performed FDG-PET-CT studies 
(mostly performed in oncological settings) throughout development in childhood 
and adolescence showed that BAT peeks up to observed amounts of ~1000g.19 
Figure 3. PET-CT-image of a healthy, young male subject under thermoneutral conditions (thermoneutral) and 
after mild cold exposure (mild cold). After mild cold exposure, the black areas indicate active uptake of FDG in 
supraclavicular and paravertebral adipose tissue. Images obtained from van Marken Lichtenbelt et al., NEJM, 
2009.17
Figure 4. Relation between Body Mass Index (BMI) and Brown Adipose Tissue (BAT) activity. Image ontained 
from van Marken Lichtenbelt et al, NEJM, 2009.17
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However, prospective, controlled studies in healthy adolescents using metabolic 
imaging techniques show average volumes of BAT of ~100g or ~100cm3 (range 
0-296 cm3).17 Both the amount of BAT and the number of anatomical sites show that 
BAT decreases with age, resulting in a decline in BAT presence being restricted to the 
supraclavicular/neck area or even a total absence in the last decades of life.3,17,20 The 
mechanism underlying this change in volume and distribution of BAT through life 
is unknown.Interestingly, recent cell studies suggest that the amount and function 
of brown adipocytes can change. During the development of adipocytes several 
factors have been identified that can influence the final differentiation into white 
and brown phenotypes.21,22 Recent reports show that stimulation of WAT depots 
triggers the growth of a subset of thermogenically active BRITE (brown-in-white) 
or ‘beige’ cells.23-25 This suggests that within human WAT a subset of preadipocytes 
have a certain ‘plasticity’, which allows differentiation to thermogenic cells 
depending on environmental conditions or specific stimuli. 
Interestingly, recently biopsies from the supraclavicular adipose tissue area known to 
contain BAT in man have shown the presence of beige adipocytes and preadipocytes 
that could become thermogenically active in vitro.26,27 This ‘plasticity’ of BAT could 
Figure 5. Formalin-fixed histological slide of supraclavicular human brown adipose tissue. The multivacuolar 
aspect and dark-stained mitochondria are evident in the brown adipocyte (Vijgen et al., unpublished work).
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explain the previously observed high amounts of BAT in Finnish outdoor workers, 
who were exposed for longer periods of cold compared to their colleague indoor 
workers.28 Therefore, possibly BAT in adult man could increase when stimulated to 
a similar extent as long-term cold exposure. Theoretically, BAT grafts developed 
ex-vivo could be implanted in subjects with low or absent BAT. However, this is not 
possible yet and at this moment most studies focus on determining the physiological 
and pathophysiological importance of BAT in man. In summary, BAT could have a 
significant role in human physiology and possibly be important in the regulation 
of the energy balance and weight maintenance, similar to the situation in small 
mammals. Therefore, this raised renewed interest in BAT in adult humans and its 
metabolic role in relation to obesity. 
Role of brown adipose tissue in obesity
Obesity and its comorbidities were already stated as diseases by Hippocrates in 
his De Priscina Medicina (400 BC): “corpulence is not only a disease itself, but the 
harbinger of other diseases”.29,30 In the past under more natural living conditions, 
the excess amount of adipose tissue in obesity served as an energy source during 
periods of food scarcity. In modern times food is always available and more than 
10% of the world’s adult population is obese, making obesity one of the biggest 
health threats in the Western world.31,32 Obesity is strongly associated with other 
diseases, such as type II diabetes, cardiovascular disease, dyslipidemia and cancer.33 
The rapidly increasing incidence of obesity and its associated diseases demand for 
both a preventive and curative strategy. Most obesity therapies aim at restoring the 
disturbed energy balance by either decreasing energy intake or increasing energy 
expenditure. Caloric restriction may be successful on short term,34 but unfortunately 
it is extremely difficult to maintain weight loss, as shown by long-term follow-up 
studies.35 One of the first promising drugs targeting obesity was 2,4-dinitrophenol 
(DNP), developed in the 1930s. DNP caused rapid weight loss by increasing energy 
expenditure through uncoupling of mitochondrial oxidative phosphorylation.36 
However, severe adverse effects such as hyperthermia made this drug unsuitable for 
large-scale use. During the last decades, several drugs were released that aimed at 
decreasing energy intake.37 These substances targeted the central nervous system 
(sibutramine, rimonabant, phentermine, diethylpropion), cellular (rosiglitazone) and 
digestive components (orlistat) of obesity and initially showed significant long-term 
weight losses of 2.9-4.7 kg up to 5-10 kg after 2 years.34,37,38 However, increased 
cardiovascular risks (rosiglitazone), mood disorders (rimonabant) and abdominal 
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complaints (orlistat) made that these drugs are currently not recommended 
anymore.37 Therefore, more rigorous treatments are sometimes inescapable, 
for example in morbid obesity. In these patients invasive bariatric surgery is an 
effective long-term weight loss therapy.39,40 In search for less invasive treatments, 
the quest for the ‘holy grail’ in obesity treatment continues and in the past years 
BAT has gained increasing scientific interest as a possible therapeutic target tissue 
for obesity in man. 
In man, most studies using imaging techniques first expose study subjects to mild 
cold to induce BAT activity. The mild cold exposure sensitizes skin neurons and is 
then believed to stimulate an increase in sympathetic nervous system (SNS) activity. 
This increased SNS activity stimulates synapse norepinephrine (NE) release which 
induces ß-adrenergically-mediated BAT activity.5 Interestingly, although ß-receptors 
are present in human BAT,18 the exact ß-adrenergic stimulus is not known yet. 
Recent imaging studies targeting ß-adrenergic BAT stimulation with isoprenaline 
and ephedrine (1.0mg/kg) were unsuccessful and only high doses of ephedrine 
(2.5mg/kg) were able to induce some BAT activity in lean but not obese humans.41-
43 Therefore, a more detailed, cellular investigation of BAT is necessary to identify 
the molecular mechanisms that eventually induce UCP1-mediated mitochondrial 
uncoupling in the brown adipocyte to target BAT activation. 
In summary, most therapeutic strategies for obesity aiming at a long-term reduction 
of energy intake are unsuccessful and to date no treatment has been able to 
sustainably increase energy expenditure. Possibly, BAT can be of great value in 
future obesity treatment. This thesis deals with the physiology of BAT in obesity 
and therapeutic options to induce BAT activity in man are explored.
Outline of the thesis
This thesis describes studies on the physiology and pathophysiology of BAT in man, 
in relation to the treatment of obesity. In Chapter 2, the clinical relevance of BAT in 
man is discussed. In Chapter 3, we observed BAT activity in morbidly obese subjects 
in comparison to previously studied lean subjects. Next, the effect of major weight 
loss by bariatric surgery in morbidly obese subjects on presence and activity of BAT 
was studied (Chapter 4). Since recent studies have shown that heat production in 
BAT and skeletal muscle could be closely related, we studied the effect of weight 
loss on skeletal muscle mitochondrial function (Chapter 5). Chapter 6 describes a 
study on the cellular physiology and the metabolic capacity of human brown and 
white adipose tissue. Chapter 7 describes a study on the effect of central nervous 
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system stimulation on BAT activity in patients with refractory epilepsy who are 
treated with vagus nerve stimulation. Finally, in Chapter 8, the results obtained in 
this thesis are discussed and implications and applications for further research are 
presented.
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Chapter 2
-
Brown adipose tissue; clinical impact of a re-
discovered thermogenic organ
The contents of this chapter are accepted for publication in Frontiers in Bioscience.
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Abstract
Brown adipose tissue (BAT) is physiologically present and active in adult humans. 
The stimulation of BAT in man can potentially increase total daily energy 
expenditure and is seen as a possible target to treat obesity. Altered BAT activity 
is also related to other diseases and therefore the therapeutic potential of BAT 
could reach beyond obesity. This is supported by both in vitro and in vivo reports 
from animal studies, describing the possible role of BAT in both physiology and 
pathophysiology. In addition, since the discovery of functional BAT several clinically 
relevant studies have been conducted in adult man. Clinical observations report BAT 
activity under multiple conditions, suggesting BAT could be important in the onset 
and/or treatment of diseases related to the metabolic syndrome, thyroid disorders, 
cancer and immune system dysfunction. This review highlights those diseases or 
syndromes in which BAT may play a role in relation to prevention, diagnosis or 
therapy, by translating basic research into clinical relevance. 
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Introduction
Recently, active brown adipose tissue (BAT) was discovered in healthy adults.1-3 In 
rodents, BAT is known for of its high heat production capacity that can significantly 
increase total energy expenditure.4 Since the discovery of functional BAT in 
man, increasing energy expenditure by the stimulation of BAT is seen as a new 
anti-obesity target.5,6 Interestingly, in man BAT activity is low or absent in obese 
subjects. Possibly, increasing energy expenditure by stimulation of BAT could be 
important in weight maintenance or could create a negative energy balance leading 
to weight loss.
Studies in both man and animals also show active BAT under several clinical 
conditions. These studies suggest involvement of BAT in conditions that are 
associated with the metabolic syndrome (obesity, type 2 diabetes, dyslipidemia, 
fatty liver disease), endocrine disorders (pheochromocytoma, thyroid gland 
dysfunction), neoplasms (cancer cachexia, hibernoma), general inflammation and 
the immune response. Here, we will discuss the relevance of BAT in relation to these 
conditions, and its possible therapeutic impact.  
Physiology of BAT
Classically, BAT is associated with cold exposure. To prevent hypothermia, increasing 
insulation (clothing) and change of environment are effective behavioral strategies. 
However, if this is not possible or insufficient, generating body heat is necessary to 
prevent hypothermia. Shivering in skeletal muscle is very effective to increase heat 
production, but this cannot be sustained for longer periods of time.7 Interestingly, 
when a subject is exposed to cold, heat production already increases prior to the 
onset of shivering.8 This process is defined as nonshivering thermogenesis (NST). In 
rodents BAT is the main site for NST.4 In man, there are indications that both BAT 
and skeletal muscle are involved.9 
Mitochondrial uncoupling induces thermogenesis in BAT
NST in the brown adipocyte is facilitated by ‘uncoupling’ of the mitochondrial 
respiration from adenosine-tri-phosphate (ATP) production. The mitochondrial 
respiration chain generates a proton gradient across the inner mitochondrial 
membrane to produce ATP. However, during BAT stimulation the cross-membrane 
proton gradient is used to produce heat instead of ATP. An essential protein for this 
process, that also typifies BAT, is the uncoupling protein 1 (UCP1, Figure 1).4 In order 
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to facilitate uncoupling by UCP1 in the brown adipocyte, free fatty acids (FFAs) are 
necessary.4 The exact contribution of FFAs to UCP1 activation is still unknown, 
but most likely they facilitate a membrane entrance for protons to generate 
thermogenesis.4 Besides FFAs, BAT also uses glucose during thermogenesis.4 The 
purpose of glucose-uptake in active BAT is largely unknown. Possibly, glucose is 
necessary to maintain the citric cycle, ATP production and the proton gradient 
4. Alternatively, glucose is converted to FFAs.4 The function of glucose uptake in 
BAT would then be to increase the amount of FFAs, necessary for mitochondrial 
uncoupling.
Involvement of sympathetic nervous system in BAT activation
The sympathetic nervous system (SNS) stimulates BAT to produce heat during 
NST. Sympathetic innervation is essential for BAT to become active, as disruption 
of the sympathetic fibers to BAT completely ceased BAT activity.10 In man, most 
Figure 1. Uncoupling protein 1 (UCP1) mediates mitochondrial uncoupling in brown adipose tissue (BAT). 
Schematic overview of BAT (top left), BAT mitochondrion (top right) and inner mitochondrial membrane (A 
and B). The proton gradient across the inner mitochondrial membrane can be used to generate ATP (cou-
pled respiration, depicted in A). When BAT is stimulated to become active, UCP1 facilitates uncoupling of 
ATP-generation to induce thermogenesis (uncoupled respiration, depicted in B).
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likely responses from warm- and cold sensitive neurons regulate the activation of 
thermogenesis.11 In the hypothalamus and medulla input from these neurons is 
mediated into sympathetic stimuli that control BAT thermogenesis by the release 
of norepinephrine on the adrenergic receptors of BAT cells.11 In rodents, BAT 
activity is associated with both adrenergic α- and ß-receptor subtypes. Although 
the  α1A-receptor is abundant in BAT, stimulation could only account for maximally 
10% of total BAT thermogenesis in rodents.4 The α2-receptor is even suggested to 
inhibit thermogenesis. The ß3-receptor seems to be the most significant mediator of 
thermogenesis, as suggested from studies that have compared BAT stimulation with 
ß3-agonists versus norepinephrine.
4 Most likely ß3-activation, and to a much lower 
extent α1A-activation, mutually mediate norepinephrine-induced thermogenesis in 
mammals. Although present in BAT, the ß1-receptor is only suggested to influence 
BAT activity when ß3-receptor signaling is dysfunctional (e.g. ß3-receptor-ablation).
4 
Thyroid hormone induces BAT activation
In addition to sympathetic stimulation of BAT, thyroid hormone plays a significant 
role in BAT thermogenesis. The thyroid gland mainly secretes the inactive 
pro-hormone thyroxine (T4), which needs to be deiodinised (lose an iodine atom) by 
deiodinases to triiodothyronine (T3) to become active. In rodents, T3 can stimulate 
BAT.12 After conversion of T4 to T3 by the BAT-specific type-II-iodothyronine-5-
deiodinase (D2), thyroid hormone enhances BAT thermogenesis.12,13 In addition, 
thyroid hormone suppletion in the brain increased BAT activity and induced weight 
loss in rodents.13 This activation of BAT could then be reversed by the β3-adrenergic 
receptor antagonist SR59230A, indicating this central thyroid activation was 
mediated via the SNS.13 These results indicate interplay at the central nervous 
system level between the endocrine (thyroid axis) and sympathetic regulation of 
BAT. 
Presence of BAT in man
In humans, BAT is present in significant amounts during childhood. Compared to 
adults, newborns have several disadvantages regarding their maintenance of body 
temperature. The higher body surface-to-volume ratio may cause a more rapid heat 
loss. Due to low amount of muscle, the ability to induce thermogenesis by shivering 
is limited. Therefore NST is important in newborns.4 During infancy growth changes 
the relative surface area and the amount of BAT gradually decreases. In adulthood 
BAT has been reported in autopsies,14 but it was always believed to be dysfunctional.15 
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Strikingly, BAT has recently shown to be present in significant amounts in adults 
and becomes functionally active upon cold exposure.1,2 2-deoxy-2-18F-fluoro-D-
glucose (18F-FDG), a radioactive labeled glucose tracer, is used in nuclear imaging 
(positron-emission-tomography-and-computed-tomography (PET-CT)) to depict 
glucose uptake for tumor diagnosis. Frequently non-malignant uptake in adipose 
tissue was seen, which later appeared to be related to mild cold conditions during 
the tracer administration. Prospective, controlled mild cold exposure consistently 
showed this activity in supraclavicular, cervical and paravertebral adipose tissue 
regions. Tissue biopsies from PET-active supraclavicular adipose tissue regions 
confirmed BAT presence.1,2 
Retrospective 18F-FDG PET-CT series in infants show high amounts of BAT that even 
increase during adolescence.16 In adolescence, muscle mass also still increases under 
influence of metabolic and hormonal factors.16 Seale et al. showed that skeletal 
muscle and BAT share a similar developmental origin 17 and therefore it is suggested 
the factors that induce muscle growth during adolescence could similarly influence 
BAT.16 After the volume of BAT peeks up to amounts of 1200 cm3 in the second 
decade of life,16 18F-FDG PET-CT studies 3 and histological analyses 18 indicate the 
amount of BAT decreases with age. BAT expresses sex hormone receptors and the 
age-related involution of BAT could be influenced by the lowering levels of sex 
hormones.19 If low BAT is related to disease, the age-related BAT loss could be 
important in the onset of the metabolic syndrome and other pathologic conditions. 
BAT in disease
Metabolic syndrome
Obesity
In mice, absence of active BAT through ablation of UCP1 causes a weight gain 
of >50% within 30 days after birth.20 In man, dedicated studies show a strong 
negative correlation with BAT activity and body fat percentage and body mass 
index.1,3,21 Retrospective analyses of patient 18F-FDG PET-CT-scans reveal 
comparable relations.22-25 Possibly, due to the insulation by subcutaneous adipose 
tissue in obese subjects there is less need to activate BAT in daily living situations. 
Subjects without BAT activity show significantly lower NST,21,26 suggesting BAT is 
involved in the human energy balance. A classic overfeeding study in man showed 
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large differences in weight gain on a high-calorie diet.27 If low or absent BAT 
activity would be responsible for the differences in weight gain after overfeeding, 
increasing BAT activity could possibly prevent or treat obesity. An explanation 
for the individual variation in BAT could be associated with polymorphisms in the 
UCP1-gene. Resting energy expenditure, sympathetic nervous system activity 
and the thermal effect of a meal show a relation with the UCP1 G/G genotype.28 
Moreover, if the UCP1 G/G genotype is accompanied by a Trp64Arg polymorphism 
of the ß3-receptor gene this is associated with a lower basal metabolic rate, lower 
sympathetic nervous system activity and a higher amount of visceral adipose 
tissue.29,30 However, there are no studies that have directly related BAT activity and 
UCP1-polymorphisms yet.
In summary, active BAT is low or absent in obesity. Body composition (body fat 
percentage) and environmental factors (lifestyle) may cause variations in amount 
and activity of BAT. Increasing BAT activity could be a new target to both prevent 
and treat overweight.
Type 2 diabetes
The significant uptake of glucose in active BAT is shown by 18F-FDG PET-CT. 
Stimulating glucose uptake in BAT can be beneficial in situations of impaired 
glucose clearance, as in type 2 diabetes. Indeed, retrospective cohort studies 
suggest an association with high blood glucose levels and absence of active BAT on 
18F-FDG PET-CT.24,31,32 Interesting is the case of a patient with a resected thyroid 
gland because of thyroid cancer and an extreme insulin resistance due to an insulin 
receptor mutation.33 The therapeutic treatment of this patient with high doses of 
thyroid hormone was accompanied with an increase of active BAT. The suppletion 
with thyroid hormone also resolved the patient’s hyperglycaemia, hinting towards 
an association between BAT activity and glucose homeostasis. 
To estimate the glucose clearing capacity of BAT in man, the uptake of glucose 
in cold-stimulated BAT can be used. Calculations made from dynamic 18F-FDG 
PET-CT scans during cold exposure show a mean glucose clearance in BAT of 
9.1±5.1 µmol/100 g/minute (n=27) 34 to 22.67±18.28 µmol/100 g/minute (n=5) 
(unpublished results). To assess the possible contribution of cold stimulated BAT on 
whole body glucose clearance, glucose uptake in BAT (0.7mMol glucose for 100g 
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BAT per hour, based on reports above) can be compared to the glucose infusion 
rate in a hyperinsulinemic-euglycemic clamp test (166mMol glucose per hour).35 
In this comparison, BAT accounts for 0.4% of the body’s maximal glucose uptake. 
In summary, active BAT takes up glucose and BAT in man can be important in 
glucose clearance. Therefore, BAT is a new potential target tissue for the treatment 
of type 2 diabetes.
Dyslipidemia
FFAs are essential for BAT thermogenesis (see Physiology of BAT). They are delivered 
to BAT by plasma circulating triglyceride-rich lipoproteins (TRLs) and cold-activated 
BAT in mice cleared a large amount of TRLs from the blood after a meal.36 On a 
cellular level, BAT-released lipoprotein lipase (LPL) converted the TRLs to free fatty 
acids (FFA), then used for thermogenesis.36 In conclusion, after BAT activation by 
cold exposure experimentally induced hyperlipidemia could be corrected. Although 
the condition of cold exposure was extreme (4ºC), the reported high clearance of 
plasma triglycerides (>50%) provides hope for the treatment of dyslipidemia in 
man. In man, current treatment for dyslipidemia with statins generates a 40-60% 
reduction in plasma low density lipoprotein (LDL) cholesterol, a direct lipolysis 
product of TRLs.37 Increasing BAT activity theoretically requests more lipolysis and 
could positively affect dyslipidemia. 
Hepatosteatosis
Obesity, type 2 diabetes and dyslipidemia are all associated with an increased 
accumulation of fat in the liver, defined as hepatosteatosis (or non-alcoholic 
fatty liver disease (NAFLD)). Hepatosteatosis is associated with a decrease in liver 
functionality and a high risk of developing steatohepatitis and liver cirrhosis.38 A 
retrospective analysis of 18F-FDG PET-CT-scans suggests an inverse relation between 
BAT activity and hepatosteatosis.39 Subjects without BAT activity had a significantly 
higher risk of hepatosteatosis and BAT activity was inversely correlated with the 
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level of liver steatosis and body mass index (BMI). In addition to the association 
with energy balance, genetic polymorphisms of UCP1 are also associated with 
hepatosteatosis.40 
In conclusion, hepatosteatosis is associated with low BAT activity and prospective 
studies are needed to define the role of low BAT in the development of 
hepatosteatosis.
Thyroid disease
Patients with thyrotoxicosis (high levels of plasma T4 and T3 due to a toxic goiter) 
have an increase in resting energy expenditure (REE) up to 30% that returns to 
normal values after treatment with thiamazole.41 Upon T3-suppletion (resulting in 
T3 values twice as high compared to normal) in healthy subjects basal metabolic 
rate (BMR) increased.42 During hypothyroidism (low plasma levels of thyroid 
hormone) REE decreases 20-25%.43 Even the induction of subclinical variations 
in thyroid function by suppletion of thyroid hormone already caused changes in 
REE of 5-10%.43 This indicates thyroid function is relevant for at least REE in man, 
but the contribution to thermogenesis and BAT has not been clearly defined yet. 
Support for thyroid-induced BAT activity in man is given by the above-mentioned 
case report of a patient with a resected thyroid gland because of thyroid cancer.33 
Treatment with thyroid hormone was accompanied with active BAT on 18F-FDG 
PET-CT, without cold exposure. 
Similar to the influence of thyroid hormone on REE, variations in thyroid function 
within normal ranges could also impair or stimulate BAT activity. Therefore, 
dedicated studies on thyroid function and BAT in man are necessary. 
Pheochromocytoma
The pheochromocytoma is a tumor of chromaffin-cells. In man, chromaffin cells 
are present in the medulla of the adrenal gland and secrete the catecholamines 
norepinephrine and epinephrine. During cold exposure, BAT is activated by 
sympathetic stimuli from the brain that release norepinephrine to stimulate the 
adrenergic receptors on BAT cells.11 Catecholamines released in the blood plasma 
induce adrenergic responses similar to activation of the sympathetic nervous 
system. In rodents, suppletion of norepinephrine is known to be able to increase the 
activity of BAT up to a fourfold.4 In patients with pheochromocytoma, retrospective 
18F-FDG PET-CT studies often show high BAT activity even under thermoneutral 
conditions.44,45 Interestingly, the high levels of circulating plasma catecholamines 
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in pheochromocytoma were significantly related to the level of BAT activity.25 
This suggests that the principle of catecholamine-activated BAT (by suppletion of 
norepinephrine into the circulation) as observed in rodents also applies to man. 
Cancer cachexia 
During cancer cachexia high BAT activity is reported. In autopsy studies in man high 
BAT presence in cachectic cancer patients was already described years ago.46 Active 
BAT is also often reported in 18F-FDG PET-CT-imaging of oncologic patients.47 
It is hypothesized that the high production of cytokines in cancer stimulates 
thermogenesis in BAT, both via the hypothalamus and directly on BAT cells. This 
is supported by studies in mice that show tumor implantation or stimulation with 
carcinogenic factors increases BAT activity.48 
Experimental denervation of BAT and ß3-receptor antagonism reduces the effect of 
a cytokine-induced increase in energy expenditure.49 Therefore, the tumor-induced 
high BAT activity is held responsible for the increased thermogenesis that causes 
body mass loss up to anorectic levels in cancer cachexia. 
Hibernoma
In addition to the high BAT activity in physiological depots in patients with malignant 
tumors, BAT can be present within a tumor itself.50 The rare hibernoma, a benign 
lipomatous tumor of brown adipocytes, was visible on 18F-FDG PET-CT-imaging.23 
Although the hibernoma shows activity on 18F-FDG PET-CT, its activity apparently 
seems not high enough to significantly induce weight loss.23 In spite of the fact 
large amounts of BAT are present in the hibernoma, it is not activated in daily life. 
Immune response
In rodents BAT thermogenesis increases during fever.51 In the inflammatory state 
BAT serves as the main heat-producing tissue in rodents.51 After the injection of 
lipopolysaccharide (LPS), an endotoxin present in bacteria, BAT is triggered to 
increase thermogenesis which causes fever.51 The increase in BAT activity also 
occurs in response to sympathetic stimuli from the hypothalamus, which itself is 
stimulated by pyrogenic cytokines.11 Besides the sympathetic stimulus from the 
brain, macrophages in the blood of mice are able to release catecholamines that 
activate BAT.52 Interestingly, during fever BAT starts producing its own endogenous 
pyrogens.51 BAT is reported to produce interleukin-6 (IL-6), a pro-inflammatory 
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cytokine normally secreted by cells of the immune system, e.g. macrophages. 
IL-6 is not only present during fever, but is also important during inflammation 
and infection and is seen in other immune reactions.53 In fever, IL-6 initiates the 
pyrogenic mediator prostaglandine E2 (PGE2) which in the hypothalamus increases 
the temperature setpoint.11 In this perspective BAT thus could be capable of both 
controlling the level of fever and increasing heat production. This is interesting, 
because it makes BAT not only a tissue that responds when stimulated, but also 
a controller of thermogenesis itself. Cyclooxygenase 2 (COX-2), an important 
controller of PGE2 production, recruits BRITE (brown-in-white) cells in white adipose 
tissue (WAT) of mice.54 These cells are non-thermogenic preadipocytes present in 
WAT that differ from white adipocytes because they can become thermogenic to 
similar levels as BAT.55 Others factors for BRITE recruitment are a currently further 
explored treatment target (see Stimulation of BAT). Since IL-6, COX-2 and PGE2 
are important in inflammation, increasing the amount of BAT or BRITE could be an 
interesting target to enhance the immune response during immunodeficiency. 
Besides cold induced thermogenesis, BAT may be involved in immune competence 
of neonates.56 Sudden infant death syndrome (SIDS) is associated with a depletion 
of BAT, as observed afterwards during autopsy.56 It is suggested this BAT depletion 
could follow from maternal conditions during pregnancy. Indeed, animal studies 
show that maternal cold exposure increased BAT activity in newborn lambs and 
lactation conditions were important for BAT development in mice.57,58 
Results from autopsies,14 18F-FDG PET-CT-imaging studies 3 and histological 
analyses 18 indicate the amount of BAT decreases with age. If BAT is important in 
the immune response, a lower amount of BAT in the elderly could possibly account 
to more disease susceptibility. 
In conclusion, BAT can be important for our immune system. However, more 
prospective studies on BAT activity or recruitment during fever or immune activation 
are needed. 
Stimulating BAT
Cold exposure 
Functional BAT in man was discovered by exposing subjects to mild cold.1,2 Under 
thermoneutral conditions, healthy subjects did not show active BAT.1 Indeed, 
active BAT is related to thermogenesis under mild cold exposure.21,26,59 During cold 
acclimatization (days to weeks) nonshivering thermogenesis (NST) increases.60 
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In mice, the increased NST after cold acclimatization originates from increased 
BAT activity.4 Cold acclimatization also causes recruitment of BAT in rodents and 
primates.4 
In man, high volumes of BAT were observed in autopsy studies on Finnish outdoor 
workers, who were acclimatized to cold.61 Hence, cold acclimatization could be an 
interesting treatment modality to increase energy expenditure by activating NST in 
BAT.7 
Insulin stimulation
In mice, injection of insulin in the hypothalamus increases thermogenesis by 
activating BAT.62 In man, insulin infusion increased glucose uptake in BAT five-fold 
compared to baseline, from 0.9 to 4.7 µmol/100 g/minute.34 This insulin stimulated 
glucose uptake in BAT amounted to half of the cold stimulated BAT activity. In 
contrast to glucose uptake during cold exposure, insulin-stimulated glucose uptake 
in BAT is suggested to be more active under non-thermogenic conditions (no cold 
exposure).4 Under such conditions glucose would mainly be taken up in BAT to be 
converted into FFAs, that later can be used for mitochondrial uncoupling during 
BAT activation.4
In summary, BAT can be stimulated by insulin to take up glucose under thermoneutral 
conditions. Possibly, insulin-stimulated BAT could decrease blood glucose levels and 
serve as a therapeutic target for type 2 diabetes.
Sympathetic stimulation
Sympathetic ß-receptor agonists increase SNS activity, which could possibly 
stimulate BAT thermogenesis. Interestingly, cold-induced BAT activity in man can 
be fully blocked by the ß-antagonist propranolol.63 Propranolol is highly specific for 
ß1- and ß2-receptors and rodent studies indicate BAT mainly contains ß3-receptors.
4 
This suggests BAT activity in man is mediated differently from rodents. The 
ß-agonist ephedrine was used to stimulate BAT and increase energy expenditure 
many years ago, but activation of BAT was not reported possibly due to the limited 
methods then available.15 Since ephedrine mainly stimulates ß1- and ß2-receptors 
and propranolol shows blockage of these receptors inhibits BAT, ephedrine (or 
other ß-receptor agonists) could be effective in activating BAT in man after all. 
Controversially, propranolol suppletion did not reduce cold-induced NST in man.64 
Since NST in man upon cold exposure is associated with BAT, this again supports 
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the ß3-receptor specificity of BAT seen in rodents. These contrasting results could 
possibly become more clear after an intervention study with ß3-receptor specific 
agonists.5
BAT stimulation via the gut 
In rodents, the feeding of bile acids increases fat combustion in BAT.65 This signal 
is mediated via the G protein-coupled bile acid-receptor TGR5 (TGR5), present on 
BAT.66 TGR5-agonists increase energy expenditure, decrease non-alcoholic fatty 
liver disease (NAFLD) and improve glucose tolerance in rodents.65 Interestingly, this 
process is dependent of the thyroid hormone converter D2 (for thyroid function 
and BAT, see BAT physiology).67 If D2 is disrupted in mice, bile acids do not increase 
BAT activity anymore, indicating the importance of thyroid-induced thermogenesis 
in bile acid-stimulated BAT activity.67 
Gut hormones are involved in food intake regulation via the brain.68 Rodent studies 
indicate the central responses involved in ingestion are most likely located in the 
paraventricular hypothalamus, which is also known to induce the sympathetic 
nervous system (SNS) and thyroid axis.68 Increased SNS activity stimulates BAT 
activity, and therefore the response that mediates a decrease in food intake could 
stimulate energy expenditure in BAT. In man, this is illustrated by the observation 
that after suppletion of the appetite hormone oxyntomodulin energy expenditure 
was also stimulated.69 
In summary, the suppletion of bile acids and gut hormones could induce an increase 
in BAT activity via the gut.70 
Transforming WAT to BAT
All options described above consider the stimulation of BAT present at birth, often 
referred to as ‘native’ BAT depots. BAT in these depots was shown the share a 
developmental origin that is very similar to skeletal muscle.17 The presence or 
absence of the signaling molecule PRDM16 stimulates dermomyotomal precursors 
to end up as a skeletal muscle cell (absence of PRDM16) or as a brown adipocyte 
(PRDM16+).17 WAT seems to derive from a different developmental origin without 
the thermogenic capacity of BAT.71 However, within WAT depots a subpopulation 
of cells is indeed capable of developing into thermogenic ‘beige’ or BRITE (brown-
in-white) cells.55,71 These cells possess UCP1 and are thus capable of thermogenesis. 
Chaffee et al. already reported ‘darker yellow adipose tissue’ in rhesus monkeys 
after 12-24 months cold-acclimatization at 5ºC in comparison to controls housed 
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at 35ºC 4. Several studies have now reported the development of BRITE cells upon 
diverse stimuli under cell culture conditions and in rodents.55,72,73 Here, three studies 
are of special clinical interest because of the use of human samples.73-75 Irisin, a 
novel hormone that induced ‘browning’ and UCP1-expression in subcutaneous 
adipose tissue from mice, was shown to increase in human plasma after 10 weeks 
of exercise.75 However, this study did not study the effects of irisin on human 
adipocytes and therefore further human studies are needed. Lee et al. show in vitro 
development of thermogenic adipocytes that derive from preadipocytes isolated 
from supraclavicular adipose tissue biopsies in both FDG-PET-CT-positive (n=2) 
and FDG-PET-CT-negative (n=4) subjects.74 The stimulants used in this study were 
both ß-agonists and proliferator-activated receptor gamma (PPAR-gamma), an 
agent present in several antidiabetic agents (rosiglitazone, pioglitazone). In another 
study, Schulz et al. treated preadipocytes isolated from human subcutaneous WAT 
with a mix of several agonists and showed the induction of UCP1 presence as a 
marker of BAT.73 Although no evidence exists of BRITE recruitment in vivo in man, 
the cell studies suggest that transformation of non-thermogenic to thermogenic fat 
cells is possible in man. 
Perspective
Increasing evidence appears on the important role of BAT in adult physiology in both 
health and disease. Several recent studies illustrate possible therapeutic potentials 
of BAT (Table 1, Figure 2). This overview shows that in addition to nonshivering 
thermogenesis, BAT could be important in the metabolic syndrome (obesity, type 
2 diabetes, dyslipidemia, hepatosteatosis), neoplasms (cancer cachexia, hibernoma) 
and the immune system. However, to define the clinical impact of BAT on disease 
more basic and clinical controlled studies are needed. Recent studies clearly show 
metabolic activity of BAT in adult humans, although there are indications of 
decreasing BAT activity with ageing. Therefore, the factors that account for this 
decrease should be targets for future investigations. Since it is considered unethical 
to use PET-CT-techniques to prospectively determine BAT activity in healthy infants 
and for repeated measurements in healthy adults, less invasive techniques need 
to be developed (like magnetic resonance imaging (MRI)). On the other hand it is 
feasible to perform clinical studies on BAT activity and recruitment during existing 
therapies. Thyroid hormone suppletion, insulin therapy, weight loss treatment and 
sympathetic stimulation can provide much insight in the dynamics of BAT and 
possible clinical targets. 
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Table 1. Diseases associated with brown adipose tissue (BAT) activity and possible implications for therapy. 
Abbreviations: 1Brown adipose tissue
Disease Effect on BAT1 Evidence Potential implication
Obesity Decrease of BAT 
activity with increased 
BMI and body fat %
Retrospective 
(human) 22-25,31,32 
Prospective (human) 1,3,21
Increase BAT activity 
to prevent and/
or treat obesity
Type 2 diabetes Association with high 
blood glucose and 
absence of BAT activity
Retrospective 
(human) 24,31,32
Prospective evidence 
of insulin-mediated 
BAT activity 34
Increase BAT 
activity to decrease 
hyperglycemia
Dyslipidemia BAT activation decreases 
hyperlipidemia
Mice 36 Increase BAT 
activity to improve 
hyperlipidemia
Hepatosteatosis Association with 
absence of BAT activity 
and hepatosteatosis
Retrospective (human) 39 Absence of BAT 
activity could be 
a risk to develop 
hepatosteatosis
Hyperthyroidism Increase in BAT activity 
during hyperthyroidism
Rats 13
Target thyroid 
function to correct 
impaired BAT activity
Hypothyroidism Absence of BAT activity 
during hypothyroidism
Case-report after thyroid 
resection (human) 33
Pheochromocytoma Association with active 
BAT and high plasma 
catecholamine levels
Pheochromocytoma    
patients 44,45
Stimulation of 
sympathetic nervous 
system to induce 
BAT activity
Cancer cachexia Active BAT during 
cancer cachexia
Tumor-bearing mice 48
Autopsy (human) 46
Cancer cachexia (human) 47
Cancer-induced 
BAT activity 
increases cachexia
Hibernoma High amount of active 
BAT in hibernoma
Human 23,50 Actived BAT in 
hibernoma affects 
energy balance
Immune-activation Immune response 
influences BAT activity
Cell studies 52
Mice 54
BAT activity is 
relevant in immune 
activation
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Figure 2. Potential therapeutic targets to stimulate BAT based on clinical observations. Schematic representa-
tion of brown adipose tissue (BAT) with beta-receptors (ß3, ß1) and the bile-acid receptor TGR5. SNS indicates 
sympathetic nervous system, PPAR-gamma indicates peroxisome proliferator-activated receptor gamma, 
BMP7 indicates bone morphogenic protein 7, COX2 indicates cyclo-oxygenase-2, WAT indicates white adipose 
tissue.
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Brown adipose tissue in morbidly obese 
subjects
The contents of this chapter are published in Vijgen GH, Bouvy ND, Teule GJ, Brans 
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Abstract
Background
Cold-stimulated adaptive thermogenesis in brown adipose tissue (BAT) to increase 
energy expenditure is suggested as a possible therapeutic target for the treatment 
of obesity. We have recently shown high prevalence of BAT in adult humans, which 
was inversely related to body mass index (BMI) and body fat percentage (BF%), 
suggesting that obesity is associated with lower BAT activity. Here, we examined 
BAT activity in morbidly obese subjects and its role in cold-induced thermogenesis 
(CIT) after applying a personalized cooling protocol. We hypothesize that morbidly 
obese subjects show reduced BAT activity upon cold exposure.
Methods and Results
After applying a personalized cooling protocol for maximal non-shivering conditions, 
BAT activity was determined using positron-emission tomography and computed 
tomography (PET-CT). Cold-induced BAT activity was detected in three out of 
15 morbidly obese subjects. Combined with results from lean to morbidly obese 
subjects (n=39) from previous study, the collective data show a highly significant 
correlation between BAT activity and body composition (P<0.001), respectively 
explaining 64% and 60% of the variance in BMI (r=0.8; P<0.001) and BF% 
(r=0.75; P<0.001). Obese individuals demonstrate a blunted CIT combined with 
low BAT activity. Only in BAT-positive subjects (n=26) mean energy expenditure 
was increased significantly upon cold exposure (51.5±6.7 J/s versus 44.0±5.1 J/s, 
P=0.001), and the increase was significantly higher compared to BAT-negative 
subjects (+15.5±8.9% versus +3.6±8.9%, P=0.001), indicating a role for BAT in CIT 
in humans. 
Conclusions
This study shows that in an extremely large range of body compositions, BAT activity 
is highly correlated with BMI and BF%. BAT-positive subjects showed higher CIT, 
indicating that BAT is also in humans involved in adaptive thermogenesis. Increasing 
BAT activity could be a therapeutic target in (morbid) obesity.
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Introduction
Brown adipose tissue (BAT) is known for its capacity to generate heat in response to 
cold or diet to maintain thermal balance. The regulated production of heat is called 
adaptive thermogenesis. BAT is the main tissue for this adaptive thermogenesis 
in rodents and most likely in human infants.1,2 Although several early anatomical 
studies suggested that brown adipose tissue is present in adult humans 3-5, its 
physiologic relevance was believed to be marginal for most.5,6 However, recent 
prospective, controlled studies showed that functional BAT is detectable in lean and 
obese adult humans after exposure to mild cold.7-9 We showed a high incidence of 
cold induced BAT activity that was inversely related to body mass index (BMI) and 
body fat percentage (BF%).7 Other studies had similar findings.8-10 
Cold-stimulated adaptive thermogenesis in BAT to increase energy expenditure is 
suggested as a possible therapeutic target for the treatment of obesity.11,12 Cold 
can indeed stimulate adaptive thermogenesis, but differences in body composition 
may be correlated with the magnitude and type of response. We showed that lean 
subjects increase energy expenditure significantly in response to mild cold, whereas 
obese subjects have a blunted cold-induced thermogenesis (CIT) and show a larger 
insulative response.13 If BAT is directly responsible for CIT, the absence of CIT in 
obesity suggests that BAT is reduced or absent. In addition, if the presence of BAT 
is structurally lower in obesity, this could be a risk factor for the development of 
obesity. Not being able to burn off excess calories leads to a positive energy balance 
and predisposes to develop obesity. This could explain the differences in weight 
gain in classic overfeeding studies.14
In our previous report BAT abundance in obese subjects was relatively low, though 
detectable in most individuals. In the current study we address BAT activity in 
morbid obesity, a severe form of obesity characterized by a BMI ≥35 kg/m2 with 
concomitant disease or ≥40 kg/m2 without. 
To ensure maximal non-shivering thermogenesis (NST), as occurs before the onset 
of shivering,15 every subject was exposed to an individualized cooling protocol. We 
hypothesized that morbidly obese in comparison to lean subjects show reduced BAT 
activity upon cold exposure. Furthermore, we examined the role of BAT activity in 
cold-induced thermogenesis in these morbidly obese subjects.
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Methods   
The study was reviewed and approved by the medical ethics committee of the 
Maastricht University Medical Centre. Written informed consent was obtained from 
fifteen morbidly obese subjects, two male and thirteen female. The mean BMI was 
42.1±3.8 kg/m2 (range 34.8-48.3 kg/m2), mean body fat percentage 48.5±4.5% 
(range 37.9-54.7%), mean weight 123.9±16.7 kg (range 98.2-155.0 kg) and mean 
age 39.2±8.1 years (range 24-51 years). Subjects were not included when diagnosed 
with diabetes or use of beta-blockers. One female subject used levothyroxin for 
hypothyroidism and was euthyroid for several years. One female subject used 
azathioprine and mesalazine for Crohn’s disease. They were studied in the morning 
from 8 a.m. to 1 p.m. in a fasted state; only water consumption was allowed after 
10 p.m. the night before measurements. During the measurements the subjects 
wore light standardized clothing (socks 0.02 clo, shirt 0.09 clo, sweatpants 0.28 
clo, underwear 0.04 clo, total clo factor 0.43 clo). Core temperature was measured 
by a telemetric pill (CoreTemp, USA). This measurement failed in two subjects. 
Skin temperature was measured by wireless iButtons at the 14 ISO-defined skin 
sites.16 Subjects were placed in a specially equipped air permeable tent (Colorado 
altitude training, USA), which functioned as a transportable climate room at the 
department of nuclear medicine. The tent was cooled by an air-conditioning, which 
can be controlled to maintain the temperature inside the tent with an accuracy 
of 1°C [Kingma et al., submitted]. Subjects were placed in a semi-supine position 
in a nephrodialysis chair to lay comfortable during the personalized cooling 
protocol. Previous studies in our group showed high NST in lean subjects at the 
fixed temperature of 16ºC, without shivering.17 However, in the current study 
group pilot experiments showed a lower onset temperature of shivering, with high 
interindividual variation. Therefore we used a personal cooling protocol to ensure 
maximal NST in the morbidly obese state. The level of cooling (temperature) was 
attuned to each individual, i.e. close to the cold level that induces shivering. This 
protocol was performed with subsequent FDG-PET-CT-imaging, because the 
intraindividual response to cold exposure shows high variation.17 In order to cool the 
dorsal site of the body, a water perfused cooling mattress was used (cooling device; 
Blankett roll, Cincinatti sub zero 2000, USA). Energy expenditure was measured 
for three hours by indirect calorimetry (Oxycon, Jaeger, Germany). One hour in 
thermoneutral conditions was followed by two hours of personalized cooling. 
In the first hour the room temperature was 22.3±0.4°C (baseline), followed by 
the second hour where the temperature of the room and cooling mattress were 
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decreased until subjects subjectively reported shivering. This was confirmed by 
continuous measurement of muscle activity (pectoralis major) by use of on-skin 
electrodes attached to an electromyograph (Nicolet Viking, Nicolet Biomedical Inc, 
USA). When shivering occurred, the air and water temperatures were increased 
by steps of 1°C until shivering just stopped. In this manner NST was maximized 
for each individual without shivering. Stable cooling conditions were reached 
within 28.6±11.8 minutes. After one hour of cold exposure 74 MBq of 18-Fluoro-
Deoxy-Glucose (FDG) was injected. Cold exposure was maintained for another 
hour. To exclude the artifact of muscle activity, subjects were instructed to lay 
still. After this hour subjects were transferred to the positron emission tomography 
and computed tomography scanner (PET-CT-scanner) (Gemini TF PET-CT, Philips, 
the Netherlands). The scanning protocol and data interpretation were identical to 
our previous study protocol.7 Energy expenditure, room temperatures and body 
temperatures were sampled on a one minute basis. On a separate occasion body 
composition was measured with a dual x-ray absorptiometry (DXA, Hologic, type 
Discovery A, USA). Statistical analysis was performed with PASW Statistics 18.0 for 
Mac OS X 10.6.4. Reported data is expressed as means ±SD. Total BAT activity is 
expressed in kiloBequerel (kBq). To compare findings before and after cold exposure 
paired t-tests were used; unpaired t-tests were used to compare BAT-positive to 
BAT-negative subjects. To identify correlations between variables linear regression 
analyses were conducted. For the relation between brown-adipose-tissue activity 
and body composition, exponential curve fitting was applied.
Results  
Individual cooling conditions
Temperature conditions before the onset of shivering were variable. Stable cooling 
temperatures were established in fourteen subjects (room temperature 14.7±2.4°C, 
inlet temperature of cooling mattress 13.3±4.7°C). One female subject (BMI 
38.7 kg/m2, body fat 49.9%, age 44 years, BAT 0 kBq) did not report shivering 
subjectively nor electromyographically at the lowest possible room (12°C) and 
cooling mattress (inlet temperature of water mattress 4°C) conditions. 
Chapter 350
BAT activity
In the current morbidly obese group mean BAT activity was low (5.5±14.8 kBq, 
range 0.0-54.5 kBq). Only three female subjects showed a cold induced increased 
FDG uptake in the neck and supraclavicular area on FDG-PET-CT-imaging (Figure 
1). In these three subjects, the BAT activity was 4.48 kBq (BMI 42.5 kg/m2, body fat 
51.2%, age 47 years), 23.61 kBq (BMI 36.9 kg/m2, body fat 50.8%, age 47 years) 
and 54.45 kBq (BMI 46.3 kg/m2, body fat 53.7%, age 32 years). No BAT activity 
was detected in the other 12 subjects.
Energy expenditure
On average, energy expenditure during cooling compared to baseline did not 
increase significantly (baseline 41.9±3.3 J/s, mild cold 43.7±4.8 J/s, P=0.100) 
(Table 1). However, a large interindividual variation was evident. The calorimetry 
measurement in one female subject failed and was excluded from analysis.
Core and skin temperature
During cooling we observed a significant rise in core temperature (37.2±0.4°C 
in thermoneutral conditions (TN) versus 37.5±0.3°C during cold exposure (TCold), 
P=0.048) and a drop in mean skintemperature (TN 31.7±0.6°C versus TCold 
27.7±1.5°C, P<0.001) (Table 1). Compared to thermoneutral conditions, cooling 
significantly increased the core-mean skin temperature gradient (TN 5.6±0.6°C 
versus TCold 9.9±1.6°C, P<0.001) (Table 1).
Relationship of BAT - BMI
When combining the data from the current and our previous study,7 we found 
strong correlations between BAT activity and BMI (r=0.80, P<0.001), BAT activity 
and body fat mass (r=0.80, P<0.001), and BAT activity and BF% (r=0.75, P<0.001) 
(Figure 2).
In the combined group there were 26 subjects that showed active BAT on cold 
exposure, whereas 13 subjects did not. We therefore reanalysed our energy 
expenditure data in BAT-positive and BAT-negative subjects (age: 26.1±7.1 yrs, 
range 18-47 yrs versus 37.1±9.4 yrs, range 20-51 yrs, P=0.001, and body fat 
%: 25.9±11.9% versus 47.2±4.7%, P<0.001 in BAT+ vs BAT- resp.). There was 
no difference in fat free mass, an important contributor to resting metabolic 
rate (RMR), between both groups (68.6±9.9 kg versus 64.2±9.8 kg, P=0.195). 
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RMR under thermoneutral conditions did not differ between BAT-positive and 
BAT-negative subjects (44.6±5.2 J/s versus 42.4±3.3 J/s, P=0.123), but after cold 
exposure BAT-positive subjects showed a higher energy expenditure (51.5±6.7 J/s 
versus 44.0±5.1 J/s, P=0.001). Very interestingly, mean energy expenditure after 
cold exposure increased significantly within the BAT-positive group, but not within 
the BAT-negative group (+15.5±8.9% versus +3.6±8.9%, P=0.001, Figure 2C). 
In the BAT-negative group the core temperature was higher, both in thermoneutral 
conditions (37.1±0.4ºC versus 36.7±0.4ºC, P=0.018) and after cold exposure 
(37.4±0.4ºC versus 36.9±0.3ºC, P=0.001). However, mean skin temperatures did 
not show a significant difference in thermoneutral conditions (31.9±0.6ºC versus 
32.3±0.7ºC, P=0.076), nor during cold exposure (28.0±1.2ºC versus 28.6±1.2ºC, 
P=0.135). The gradient between core temperature and mean skin temperature was 
larger in the BAT-negative group in thermoneutral conditions (5.3±0.5ºC versus 
4.5±0.8ºC, P=0.004) and during cold exposure (9.6±1.5ºC versus 8.3±1.4ºC, 
P=0.023). The gradient between core temperature and mean skin temperature was 
larger in the BAT-negative group in thermoneutral conditions (5.3±0.5ºC versus 
4.5±0.8ºC, P=0.004) and during cold exposure (9.6±1.5ºC versus 8.3±1.4ºC, 
P=0.023).
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TN Min Max Cold Min Max P value
Energy expenditure (J/s) 41.9±3.3 37.9 49.6 43.7±4.8 35.7 51.1  0.100
Body core temperature (ºC) 37.2±0.4 36.5 37.8 37.5±0.3 36.9 37.9   0.048
Mean skin temperature (ºC) 31.7±0.6 30.4 32.9 27.7±1.5 25.2 29.6 <0.001
Core-mean skin gradient (ºC) 5.6±0.6 4.9 6.7 9.9±1.6 7.3 12.2 <0.001
Table 1. Energy expenditure, body core temperature, mean skin temperature and core-skin temperature gradi-
ent in thermoneutral conditions (TN) and during mild cold (Cold) in morbidly obese subjects. 
Figure 1. PET-images of fifteen morbidly obese subjects. Three female subjects showed BAT activity in the 
supraclavicular area, highlighted by a red rectangle (A). Combined PET- and CT-imaging shows FDG-uptake 
in supraclavicular adipose tissue (this was the morbidly obese subject that showed the most BAT activity) (B). 
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Figure 2. Brown adipose tissue activity in relation to body mass index (A) and body fat percentage (B). The 
black dots indicate the current study group, the open dots indicate previously performed measurements. 
Cold-induced thermogenesis (CIT), denoted in percentages, is significantly increased in 26 BAT-positive 
(BAT+) compared to 13 BAT-negative (BAT-) subjects (C). *: P<0.05
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Very interestingly, mean energy expenditure after cold exposure increased 
significantly within the BAT-positive group, but not within the BAT-negative group 
(+15.5±8.9% versus +3.6±8.9%, P=0.001, Figure 2C). 
In the BAT-negative group the core temperature was higher, both in thermoneutral 
conditions (37.1±0.4ºC versus 36.7±0.4ºC, P=0.018) and after cold exposure 
(37.4±0.4ºC versus 36.9±0.3ºC, P=0.001). However, mean skin temperatures did 
not show a significant difference in thermoneutral conditions (31.9±0.6ºC versus 
32.3±0.7ºC, P=0.076), nor during cold exposure (28.0±1.2ºC versus 28.6±1.2ºC, 
P=0.135). The gradient between core temperature and mean skin temperature was 
larger in the BAT-negative group in thermoneutral conditions (5.3±0.5ºC versus 
4.5±0.8ºC, P=0.004) and during cold exposure (9.6±1.5ºC versus 8.3±1.4ºC, 
P=0.023). 
Discussion
In this study active BAT was detected in only three out of fifteen morbidly obese 
patients, suggesting that morbid obesity is associated with low BAT activity. On 
the other hand, the data also demonstrate that even in this group BAT is present in 
some subjects and can be activated by cold exposure. Nevertheless, the combined 
results of morbidly obese subjects with those of previously reported lean and obese 
subjects, clearly show that body composition is highly related to BAT activity. This is 
in line with lower UCP-1-presence in the intraperitoneal adipose tissue of morbidly 
obese compared to lean subjects.18  
A limitation in our analysis is fact that our previous study was composed of male 
subjects, whereas the morbidly obese subjects were mostly females. However, 
retrospective studies have actually shown higher BAT activity in women,19,20 which 
would only further strengthen the conclusion that BAT activity is reduced in obesity. 
The obese subjects generally show a high insulative response. Therefore, it is 
important to note that we used an individualized cold exposure protocol that 
achieves maximal non-shivering conditions. Despite this approach, the major part 
of obese and morbidly obese subjects did not show BAT activation. In the three 
BAT-positive morbidly obese subjects, two subjects showed pronounced CIT (BAT 
23.61 kBq; CIT 18.76%, BAT 4.48 kBq; CIT 6.04%). Unfortunately, in the third 
subject (BAT 54.45 kBq) measurement of energy expenditure  failed for technical 
reasons. However, CIT in the two BAT positive morbidly obese subjects was high 
compared to the average of the morbidly obese group (mean CIT 4.45±9.33%). 
This suggests a possible relation between active BAT after cold exposure and CIT. 
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Since approximately two-thirds of the total group of subjects showed cold-induced 
BAT activity whereas one-third did not, we further tested the hypothesis that 
BAT-positive subjects would have higher (cold-induced) thermogenesis. Interestingly, 
subjects that have active BAT also have a significant increase in energy expenditure 
during cold exposure, whereas cold exposure did not increase energy expenditure 
in BAT-negative subjects. Although age is significantly different in BAT-positive and 
BAT-negative subjects, the range between both groups (18-47 yrs versus 20-51 yrs) 
strongly overlaps, with active and inactive BAT spread over all age quartiles. 
After we had previously shown that BAT activity was related to RMR, the additional 
analysis in this study shows that BAT activity may in fact be involved in adaptive 
thermogenesis. The role of FFM in this process can be excluded, since there is no 
significant difference in FFM between the analyzed groups. Therefore, the data 
suggest that - like in rodents - BAT is indeed involved in cold-induced thermogenesis 
in humans. This is in line with earlier findings in small study groups.10 
The main native BAT depot is located supraclavicular.3 That depot shows FDG-uptake 
after cold exposure in all subjects with active BAT. Biopsies taken from this region 
show typical BAT cells, mostly surrounded by white fat cells.8,21 A pure BAT depot, 
as seen in rodents, is rare in adult man. Next to native BAT, recently ‘brite’ or ‘beige’ 
cells derived from white adipose tissue were reported.22-25 These cells stem from a 
different cell lineage than native BAT, but they possess the ability to generate heat 
by mitochondrial uncoupling similar to native BAT cells. 
Most morbidly obese subjects in this study had no detectable BAT activity after 
cold exposure. From our study, it cannot be concluded that the lack of BAT is cause 
or consequence of severe obesity in our subjects. However, when the amount of 
native BAT is minimal or absent, this could lead to severe overweight. For example, 
mice that lack UCP-1, essential for mitochondrial uncoupling in BAT, become obese 
when studied under thermoneutral conditions.26 With a congenital shortage of 
native BAT, brite cells could therefore be of great therapeutic interest. 
On the other hand, in adult man a high amount of thermogenic potential can be 
present throughout the body, but may remain dormant when insulation makes a 
metabolic response unnecessary, as may be the case in the morbidly obese state. 
Indeed, prolonged cold exposure in rodents and rhesus monkeys increases the 
amount of (brite) BAT, supporting the idea of recruitable BAT.1 It would therefore 
be interesting to test if BAT can be recruited in morbidly obese subjects. Next to 
prolonged cold exposure, other therapeutic targets could recruit BAT: a) weight 
reduction decreases the insulative capacity that blunts CIT, b) pharmacological 
intervention, such as sympathicomimetics has a high potential and c) implantation 
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of cultured brown adipocytes could all counteract severe overweight.12,27 
In conclusion, this study shows that in an extremely large range of body compositions, 
BAT activity is highly correlated with BMI and BF%. Active BAT was seen in three 
out of 15 morbidly obese subjects. BAT-positive subjects showed higher CIT, 
indicating that BAT is also in humans involved in adaptive thermogenesis. 
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Chapter 4
-
Increase in brown adipose tissue activity 
after weight loss in morbidly obese subjects
The contents of this chapter are published in Vijgen GH, Bouvy ND, Teule GJ, 
Brans B, Hoeks J, Schrauwen P, van Marken Lichtenbelt WD. Journal of Clinical 
Endocrinology and Metabolism. 2012 Jul;97(7):E1229-33.
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Abstract
Background
Stimulation of thermogenesis in brown adipose tissue (BAT) is a potential target to 
treat obesity. We earlier demonstrated that BAT activity is relatively low in obese 
subjects. It is unknown whether BAT can be recruited in adult humans. 
Methods
Ten morbidly obese subjects eligible for laparoscopic adjustable gastric banding 
(LAGB) surgery were studied before and one year after bariatric surgery. The main 
outcome measure was BAT activity, as determined after acute cold stimulation 
using 18F-fluoro-deoxyglucose positron-emission-tomography and computed-
tomography (FDG-PET-CT). 
Results
Before surgery, only two out of 10 subjects showed active BAT. One year after 
surgery the number of subjects with active BAT was increased to five. After weight 
loss, BAT-positive subjects had significantly higher non-shivering thermogenesis 
(NST) compared to BAT-negative subjects (P<0.05). 
Conclusions
The results show that in humans BAT can be recruited in the regions where it 
was also reported in lean subjects before. These results for the first time show 
recruitment of BAT in humans and may open the door for BAT targeted treatments 
of obesity.
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Introduction
Until very recently, the role of brown adipose tissue (BAT) in human physiology 
was only considered to be of importance during the first years of life. However, 
metabolic imaging techniques (18-Fluoro-Deoxy-Glucose-Positron-Emission-
Tomography-and-Computed-Tomography (18F-FDG-PET-CT)) showed functionally 
active BAT upon cold exposure in adult man.1-4 We previously found that BAT activity 
is inversely related to body mass index (BMI) and body fat percentage (BF%).2 This 
could suggest that a low level of BAT activity may predispose to obesity, when 
assumed that BAT activity is an intrinsic characteristic of an individual. Alternatively, 
low BAT activity may be an adaptive trait of obesity – for example due to improved 
insulation – which would predict that functional BAT could be re-recruited when body 
composition would change, for example after significant weight loss. Post-obese 
subjects indeed report an increased cold sensation during weight loss by bariatric 
surgery.5, personal observations It is still unknown if BAT can be recruited in man. However, 
the principle of recruitable BAT has been observed after prolonged cold exposure 
in rodents and primates.6 In man, seasonal variation influences BAT activity within 
subjects.3,6 In vitro stimulation of white adipose tissue (WAT) with peroxisome 
proliferator-activated-receptor-gamma (PPAR-gamma) induced the development 
of thermogenic ‘brite’ adipocytes.7 Moreover, treating preadipocytes isolated from 
human subcutaneous adipose tissue with bone-morphogenic-protein-7 (BMP7) 
showed brown adipogenesis.8 Based on these observations, BAT recruitment in man 
seems feasible but has not yet been shown. Therefore, we investigated BAT activity 
in ten morbidly obese patients before and one year after laparoscopic adjustable 
gastric banding (LAGB) surgery as a model for caloric restriction. 
The increase in energy expenditure that is observed upon mild cold exposure in 
absence of shivering in skeletal muscle is defined as non-shivering thermogenesis 
(NST).9 Active BAT in adult man is suggested to contribute to NST. Indeed, subjects 
with active BAT show significantly higher NST than subjects without BAT activity.10,11 
Therefore we also studied NST in our subjects. 
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Methods
Approval was obtained from the local ethical commission. Written informed 
consent was received from two male and eight female morbidly obese subjects, 
with a mean BMI of 41.7±4.4 kg/m and a body mass of 127.0±17.7 kg. One female 
subject used levothyroxin for hypothyroidism and was euthyroid for several years. 
Diabetes mellitus and use of beta-blockers were strict exclusion criteria.
Study protocol
All measurements took place several weeks before surgery between 8 a.m. to 1 p.m. 
under overnight fasted conditions. In the morning, subjects put on light standardized 
clothing (socks 0.02 clo, shirt 0.09 clo, sweatpants 0.28 clo, underwear 0.04 clo, 
total clo factor 0.43 clo,12). Body composition (body fat%, fat mass (FM), fat free 
mass (FFM)) was determined by dual x-ray absorptiometry (DXA, Hologic, type 
Discovery A, USA). To determine body core temperature, a telemetric pill was orally 
ingested (CoreTemp, USA). Skin temperature was measured by applying iButtons at 
14 ISO-defined skin sites.13 Next, subjects were placed in a specially adapted climate 
controlled tent (Colorado altitude training, USA). The temperature inside the tent 
was regulated by an air conditioner (accuracy of tent air temperature: ±0.5°C). 
Energy expenditure was measured by indirect calorimetry using a ventilated hood 
system (Oxycon, Jaeger, Germany). 
Personal cooling protocol and 18F-FDG-PET-CT
In all subjects we performed the personal cooling protocol described earlier.10 
In short, subjects were placed in the climate tent. They rested semi-supine on a 
nephrodialysis chair, covered with a water-perfused mattress. To ensure maximal 
non-shivering thermogenesis, every subject was cooled until they reported shivering. 
Shivering was confirmed by electromyography of the m. pectoralis major. Upon the 
first signs of shivering the temperature was raised slightly (on average 1.8±0.6°C) 
to insure only non-shivering thermogenesis (NST). One hour of measuring under 
thermoneutral conditions (room temperature before weight loss; 22.8±0.6°C, after 
weight loss; 23.7±0.9°C, P=0.079, t0-t60) was followed by two hours of individual 
mild cold (t60-t180). Laser Doppler Flowmetry (Perimed PF5000, Sweden) was 
used to determine if a subject was in its thermoneutral zone.14 At the end of the first 
hour of cooling (t120), 10ml FDG was injected. After the second hour of cooling 
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18F-FDG-PET-CT-imaging was performed to quantify metabolically active BAT. The 
scanning protocol, FDG activity (74 MBq) and data analysis were identical to our 
previous study.2 
Follow-up
All subjects underwent LAGB without any perioperative or postoperative 
complications. One year after the LAGB procedure, all measurements were 
repeated. 
Statistical analysis
Total BAT activity was expressed in kiloBequerel (kBq) and Standard Uptake Value 
Table 1A. Subject characteristics in ten patients (two male, eight female) with measurements before and after 
weight loss. BMI indicates Body Mass Index. 
Before After P-value
Age (yr) 40±9 41±9
BMI (kg/m2) 41.7±4.4 29.8±4.2 <0.001
Body mass (kg) 127.0±17.7 90.8±16.7 <0.001
Body fat (%) 48.6±5.2 34.8±7.9 <0.001
Fat mass (kg) 62.1±10.9 32.4±10.5 <0.001
Fat free mass (kg) 63.5±11.7 57.7±12.2 <0.001
Table 1B. Total brown adipose tissue (BAT) activity before and after weight loss. Group values (n=10) of BAT 
activity in kiloBequerel (kBq), BAT volume (cm3), average BAT activity (kBq/cm3) and total and maximal 
Standard Uptake Value (SUVTotal, SUVMax). In addition, values are shown for the group of five subjects that were 
indicated as BAT-positive (BAT+) based on their BAT-presence after weight loss.
Before After P-value
Group BAT+ Group BAT+ Group BAT+
BAT activity (kBq) 7.8±18.0 15.6±24.0 51.5±87.8 103.0±103.6 0.147 0.153
BAT volume (cm3) 7.1±16.2 14.2±21.6 42.5±71.6 85.0±83.9 0.148 0.154
BAT activity (kBq/cm3) 0.2±0.5 0.4±0.6 0.6±0.6 1.1±0.1 0.074 0.062
SUVTotal 30.3±72.4 60.6±97.5 118.0±210.6 236.0±255.0 0.238 0.259
SUVMax 1.4±3.0 2.8±3.9 3.1±3.9 6.3±3.2 0.197 0.212
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Figure 1. Brown adipose tissue (BAT) activity before and after weight loss. (A) PET-images of five morbidly 
obese subjects before bariatric surgery (A) and after weight loss (B). (C) PET-image, CT-image and PET-CT-
fusion-image of the subject that showed the largest increase in BAT activity before (C) and after weight loss 
(D).  BAT activity was recruited in both supraclavicular and paravertebral areas, indicated by full and dashed 
arrows respectively. Full arrows indicate bilateral supraclavicular regions where BAT activity was observed 
after weight loss. Dashed arrows indicate bilateral paravertebral regions where BAT activity was observed after 
weight loss. (E) BAT activity in kiloBequerel (kBq) and Total Standard Uptake Value (SUVTotal, F) before and 
after weight loss for the five subjects depicted in (A) and (B).
Abbreviations; CT: Computed Tomography, PET: Positron Emission Tomography. Baseline characteristics of 
subjects shown are from 10. 
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(SUV, as calculated by uptake (kBq/mL) / injected dose (kBq) / patient weight (g)). 
BAT activity of each region is determined by the average SUV uptake (SUVMean) 
times the volume of the region (cm3), expressed as SUVTotal. Basal metabolic rate 
(BMR) correlated significantly to fat-free mass (FFM) before and after weight loss 
(respectively r=0.912, P=0.001 and r=0.948, P<0.001). Therefore, we corrected 
BMR for FFM using linear regression.15 Percentage of weight loss is expressed as 
[(Beginning weight - Follow-up weight) / Beginning weight) x 100]. Repeated 
measurements were compared using paired student’s t-tests. Based on BAT presence 
after weight loss, subjects were categorized as BAT-positive or BAT-negative which 
was compared using unpaired student’s t-tests. 
Results and discussion
One year after LAGB mean body composition decreased significantly by 36.1±8.3 
Figure 2. Relation between Brown Adipose Tissue (BAT) activity and Non-Shivering Thermogenesis (NST). 
(A) NST in BAT-positive (BATPos, n=5) and BAT15-negative (BATNeg, n=5) subjects before and after weight 
loss. (B) Non-shivering thermogenesis (NST) before and after weight loss. Full lines indicate subjects with BAT 
activity after weight loss (BAT-positive, n=5, one value not shown), dashed lines indicate subjects without BAT 
activity after weight loss (BAT-negative, n=5). *P<0.05
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kg with a mean percentage of weight loss of 28.65±6.23% (Table 1A). BAT activity 
was measured after applying an individualised cooling protocol. Thus, maximal BAT 
activity is achieved by low environmental temperatures just above the temperature 
that causes shivering.10 Mean room temperatures during maximal NST were 
significantly higher after weight loss (WL) (before WL: 14.2°C  (range 12-17), after 
WL: 15.7°C (range 12-21), P=0.026). Before surgery, we observed – albeit minimal 
– cold induced BAT activity in supraclavicular depots in two female subjects. Their 
mean BAT activity (39.0 kBq; range 23.6, 54.5 kBq) and volume (35.6 cm3; range 
22.5, 48.6 cm3) were low (for group results see Table 1B, baseline characteristics 
based on 10). After WL, we observed BAT in five out of ten subjects, among whom 
were the two above mentioned female subjects (Figure 1). Of these five BAT-positive 
subjects (all female, the two male subjects did not show BAT activity), one subject 
increased her BAT activity (23.6 kBq to 228.3 kBq), three previously BAT-negative 
subjects were BAT-positive after WL and one female subject decreased her BAT 
activity (54.5 kBq to 13.8 kBq). In addition to supraclavicular BAT activity, the 
depots of active BAT also included paravertebral depots in three patients (Figure 
1). There were no significant differences in body composition between subjects 
characterized as BAT-positive and BAT-negative after WL, neither before nor after 
WL. 
The basal metabolic rate (BMR) showed a significant decrease after WL (95.3±4.5 
versus 88.8±4.8 Watt, P=0.028). BAT-positive subjects (after WL) showed 
significantly higher NST compared to BAT-negative subjects (13.7±7.7 versus 
2.4±7.1%, P=0.042, Figure 2), in line with previous non-interventional studies on 
BAT and NST.10,11 
We show that the presence and activity of BAT in adult humans is dynamic and 
can increase after weight reduction. This important finding shows for the first 
time using functional tools (18F-FDG-PET-CT and indirect calorimetry) that BAT 
recruitment in humans is possible. Reduced activity of BAT could potentially impair 
total daily energy expenditure and be of importance in the development of obesity. 
LAGB induces a caloric restriction that caused significant WL. It does not seem 
likely LAGB could be responsible for other mechanisms that could have increased 
BAT, since the digestive tract is not altered. For example, gut hormones do not 
change after LAGB.16 
The increase in BAT presence after WL could be a direct effect of a decreased 
insulation due to loss of subcutaneous adipose tissue. WL significantly changed the 
thermal distribution, as demonstrated by the observed skin and core temperatures 
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(Table 2). Obese subjects show a low gradient between proximal and distal skin 
temperature during cold exposure, indicating a low level of vasoconstriction.15 
This gradient increased after WL (baseline; 0.2±1.9°C before WL and -4.0±2.4°C 
after WL, P=0.001, cold exposure; -3.1±1.9°C before WL and -6.4±2.2°C after 
WL, P=0.001), suggesting increased skin vasoconstriction. Insulation of the body’s 
core, as measured by the gradient between core and mean skin temperature, 
decreased significantly after WL (before WL; 5.6±0.6°C, after WL; 3.8±0.7°C, 
P<0.001). This indicates the insulation of the body’s core decreased, despite 
increased vasoconstriction of the skin. Compared to BAT-negative subjects, 
BAT-positive subjects showed a significantly smaller increase in core temperature 
Table 2. Core temperature (TCore), mean skin temperature (TSkin), proximal skin temperature (TProx) and 
distal skin temperature (TDist) during baseline measurements (Base) and cold exposure (Cold) before and 
after weight loss. The gradient between core and mean skin temperature is denoted as TCore-TSkin. ΔTCore 
and ΔTSkin denote differences between baseline measurements and cold exposure. Subjects are indicated as 
BAT-positive/BAT-negative based on their BAT-presence after weight loss. P-values shown are paired samples 
student’s t-tests for group, five BAT-positive (BAT+) and five BAT-negative (BAT-) subjects before and after 
weight loss. *P<0.05, **P<0.001
Before After P-value
Group BAT+ BAT- Group BAT+ BAT- Group BAT+ BAT-
TCore (°C) Base 37.2±0.3 37.3±0.3 37.1±0.4 37.0±0.3 37.1±0.3 36.9±0.3 0.176 0.532 0.103
Cold 37.4±0.4 37.5±0.3 37.3±0.4 37.1±0.3 37.1±0.3 37.0±0.4 0.010* 0.142 <0.001**
TSkin (°C) Base 31.6±0.6 31.6±0.8 31.6±0.5 33.3±0.5 33.1±0.4 33.4±0.5 <0.001** 0.013* <0.001**
Cold 27.7±1.5 27.6±2.0 27.9±1.0 29.6±1.5 30.0±1.7 29.2±1.3 <0.001**<0.001** 0.044*
TCore-
TSkin
Base 5.6±0.6 5.6±0.7 5.5±0.6 3.8±0.7 4.0±0.7 3.6±0.7 <0.001** 0.011* <0.001**
Cold 9.7±1.7 10.0±2.1 9.5±1.4 7.5±1.7 7.1±1.9 7.8±1.6 <0.001** 0.001* 0.026*
∆TCore 0.2±0.2 0.3±0.1 0.1±0.2 0.01±0.1 -.01±0.1 0.05±0.1 0.008* 0.008* 0.326
∆TSkin -3.9±1.3 -4.1±1.7 -3.8±0.9 -3.7±1.5 -3.1±1.6 -4.2±1.2 0.491 0.034* 0.401
TProx (°C) Base 31.6±1.2 32.1±1.5 31.0±0.5 34.4±0.5 34.3±0.6 34.5±0.4 0.001** 0.011* <0.001**
Cold 28.3±2.4 28.8±3.4 27.8±1.1 31.0±2.0 31.4±2.6 30.5±1.4 <0.001** 0.006* 0.027*
TDist (°C) Base 31.8±1.1 31.3±0.8 32.2±1.2 30.4±2.2 29.5±1.5 31.2±2.6 0.085 0.042* 0.517
Cold 25.2±2.2 24.6±2.7 25.9±1.6 24.6±2.3 24.3±2.6 24.9±2.1 0.187 0.600 0.265
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(∆TCore) during cold exposure, accompanied by a smaller decrease in mean skin 
temperature (∆TSkin) (Table 2), suggesting less vasoconstriction.15 Hence, increased 
thermogenesis in BAT could be responsible for this difference. 
It should be noted that the BAT activity we observed in this study is low in 
comparison to the levels observed in lean young men (51.5±87.8 kBq versus 
428±394 kBq, P=0.008, 2). BAT activity is suggested to be lower in older subjects,3 
which could possibly affect the energy balance. Therefore, further studies are 
needed to investigate the impact of BAT recruitment at this level for the long-term 
treatment of obesity. Nevertheless, this study provides the first evidence that BAT 
can be recruited in adults. 
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Chapter 5
-
Increased skeletal muscle mitochondrial 
function in morbidly obese subjects one year 
after bariatric surgery
The contents of this chapter are submitted.
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Abstract
Background
Obesity and type 2 diabetes are associated with impaired skeletal muscle 
mitochondrial metabolism. As an intrinsic characteristic of an individual, skeletal 
muscle mitochondrial dysfunction could be a risk factor for weight gain and obesity-
associated comorbidities as type 2 diabetes. On the other hand, impaired skeletal 
muscle metabolism could be a consequence of obesity. We hypothesize that marked 
weight loss after bariatric surgery increases skeletal muscle mitochondrial function 
in formerly morbidly obese subjects. 
Methods
Skeletal muscle mitochondrial function as assessed by high-resolution respirometry 
was determined in eight morbidly obese subjects (BMI; 41.3±4.7 kg/m2, Body 
Fat; 48.3±5.2%) before and one year after bariatric surgery (mean weight loss: 
35.0±8.6 kg). 
Results
ADP-stimulated respiration significantly increased after weight loss upon 
mitochondrial complex I-linked substrates (for malate+glutamate; 4.23±1.38 versus 
6.79±2.03 O2-flux, P=0.029; for malate+octanoyl-carnitine+glutamate (MOG); 
4.19±2.12 versus 8.93±4.16 O2-flux, P=0.028) as well as upon parallel electron input 
into both complex I and II (for malate+octanoyl-carnitine+glutamate+succinate 
(MOGS); 10.02±3.23 versus 13.97±6.63 O2-flux, P=0.031). 
Conclusions
We conclude that low skeletal muscle mitochondrial function is a consequence of 
obesity that significantly improves after marked weight loss induced by bariatric 
surgery. The pronounced amount of weight loss associated with bariatric surgery 
appears to be crucial since previous studies with limited weight loss remained 
without effect on skeletal muscle mitochondrial function. Future molecular studies 
should investigate the processes that are related to the observed change in skeletal 
muscle mitochondrial function upon bariatric surgery.
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Introduction
Obesity is one of the Western world’s primary health care issues and the increasing 
incidence of obesity is accompanied by an equal rise in comorbidities as type 2 
diabetes, dyslipidemia and hepatosteatosis.1 The excess amount of adipose tissue 
in obesity is associated with a dysfunction in several tissues; hepatosteatosis, which 
causes impaired liver function and increased lipid deposition in skeletal muscle is 
suggested to induce insulin resistance.1,2 In skeletal muscle from obese and obese 
type 2 diabetic subjects, a decreased mitochondrial function compared to lean and 
nondiabetic subjects has been reported. This could exacerbate the negative effect 
of IMCL accumulation on insulin sensitivity.3-7 However, although diet-induced 
weight loss decreased intramyocellular lipid content and has been shown to improve 
skeletal muscle insulin sensitivity in nondiabetic overweight subjects,8,9 skeletal 
muscle mitochondrial function (as determined by NADH-oxidase enzyme levels) 
per se did not change.8,10 This may suggest that reduced mitochondrial function 
in obesity is an intrinsic characteristic of obese subjects. However, it should be 
noted that weight loss in the above-mentioned studies was low (9-18 kg) 8-10 in 
comparison to bariatric surgery (37-42 kg) 11 and it cannot be excluded that further 
weight reduction does improve skeletal muscle mitochondrial metabolism. Indeed, 
it has been shown before that proteins associated with mitochondrial biogenesis 
in skeletal muscle were enhanced and related to improved insulin sensitivity after 
bariatric surgery, suggesting that skeletal muscle mitochondrial function may be 
suppressed by excessive body weight.12,13 However, to our knowledge no study 
has evaluated the effect of bariatric surgery on skeletal muscle mitochondrial 
function per se and therefore these findings need further confirmation. To test 
our hypothesis that skeletal muscle mitochondrial function improves after bariatric 
surgery we investigated ex-vivo skeletal muscle mitochondrial function in morbidly 
obese subjects before and one year after laparoscopic adjustable gastric banding 
(LAGB) surgery. 
Methods
Study protocol
Approval was obtained from the Maastricht University Medical Centre institutional 
review board. Written informed consent was received from two male and six female 
morbidly obese subjects who were awaiting laparoscopic adjustable gastric banding 
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(LAGB), with a mean BMI of 41.3±4.7 kg/m2 (Table 1). One female subject used 
levothyroxine for hypothyroidism and was euthyroid for several years. Diabetes 
mellitus was an exclusion criterion. 
Body composition
Body composition (Fat Free Mass, Fat Mass) was determined under fasted conditions 
by dual x-ray absorptiometry (DXA, type Discovery A, Hologic, Bedford, USA). 
Muscle biopsies
Several weeks before surgery, a muscle biopsy according to Bergström et al. 14 was 
taken under fasted conditions at ~8:30 in the morning. Part of the muscle was 
directly used for the fresh preparation of permeabilized muscle fibers as described.3 
The remaining part of the muscle was directly frozen in liquid nitrogen and stored 
at -80ºC until further analysis.
To determine skeletal muscle mitochondrial capacity, high-resolution respirometry 
was performed in permeabilized muscle fibers at 37°C in a two-chamber-Oxygraph 
(OROBOROS® Instruments, Innsbruck, Austria), essentially according to Hoeks et 
al.15 Coupled (state 3) respiration, initiated by addition of 2mM ADP, was measured 
for complex I-linked substrate combination malate+glutamate, both in the presence 
and absence of the lipid substrate octanoyl-carnitine. Coupled respiration was then 
maximized with convergent electron input through complex I and complex II, by 
adding saturating concentrations of succinate (10mM). Subsequently, mitochondrial 
respiration uncoupled from ATP synthesis (state 4) was determined via addition of 
the ATP-synthase inhibitor oligomycin. In addition, the chemical uncoupler FCCP 
(carbonyl-cyanide-4-(trifluoromethoxy)-phenylhydrazone) was used to maximize 
oxygen flux to assess maximal mitochondrial capacity (state u respiration).
Normalisation for mitochondrial DNA content
To determine mitochondrial density, the mitochondrial DNA (mtDNA) copy numbers 
were determined according to Phielix et al., 3 and all muscle biopsy samples were 
run in the same analysis. For comparison, oxygen fluxes per wet-weight muscle 
mass were normalized for mtDNA. The mitochondrial DNA copy numbers did not 
differ significantly before and after weight loss (mtDNA copy number; 960.6±425.1 
before, 868.8±386.0 after weight loss, P=0.371). All results showed similar trends 
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and significance when oxygen fluxes were not corrected for mtDNA (results not 
shown). Oxygen fluxes (O2 flux) shown are expressed as picomoles O2 x seconds
-1 
x milligrams of tissue-1 x mtDNA x 106. 
Plasma values
Plasma TSH and FT4 were measured using an electrochemiluminescence 
immunoassay (Roche, Basel, Switzerland) and a fluoroimmunoassay (PerkinElmer, 
Massachusetts, USA). Plasma insulin, glucose, FFA and the HOMA-IR were 
calculated as described.16
Follow-up
All eight subjects underwent LAGB without any perioperative or postoperative 
complications. One year after LAGB a second muscle biopsy was taken. 
Statistical analysis
Reported data were expressed as means±SD. Statistical analyses were performed 
with PASW Statistics 18.0 for Mac OS X 10.6.4. Repeated measurements before 
and one year after bariatric surgery were compared using paired student’s t-tests. 
A P-value below 0.05 was considered to be significant.
Results and discussion
Body composition was significantly altered one year after surgery (Table 1) with 
a mean weight loss of 27.9±6.6%. After a mean follow-up of 18 months, there 
was no difference in body composition compared to the one-year time point 
(body mass; 91.7±18.8 versus 91.5±18.3 kg, BMI; 29.8±4.8 versus 29.7±4.7 kg/
m2, P=0.844), which indicates patients were weight stable at the moment of the 
second muscle biopsy. 
ADP-stimulated (state 3) respiration increased after weight loss upon complex I-linked 
substrates (for malate+glutamate; 4.23±1.38 versus 6.79±2.03 O2 flux, P=0.029; for 
malate+octanoyl-carnitine+glutamate (MOG); 4.19±2.12 versus 8.93±4.16 O2 flux, 
P=0.028) as well as upon parallel electron input into both complex I and complex II 
(for malate+octanoyl-carnitine+glutamate+succinate (MOGS); 10.02±3.23 versus 
13.97±6.63 O2 flux, P=0.031), although did this not reach statistical significance 
for malate+glutamate+succinate (MGS; 9.50±2.43 versus 12.31±5.50 O2 flux, 
P=0.086, Figure 1). Leak respiration upon the ATP-synthase inhibitor oligomycin, 
Chapter 580
i.e. respiration not related to ATP synthesis (state 4 respiration), was determined 
as a marker for mitochondrial uncoupling, but remained unaffected by weight loss 
(6.13±2.66 versus 5.42±2.37 O2 flux, P=0.093, Figure 1). The relative contribution 
of state 4 to state 3 respiration (uncoupling ratio; UCR) decreased significantly after 
weight loss (0.63±0.19 versus 0.45±0.07, P=0.049, Figure 1). Maximally uncoupled 
mitochondrial respiration, as analysed after addition of FCCP in the presence of 
octanoyl-carnitine, did not increase significantly after weight loss (14.9±4.45 versus 
18.04±8.18 O2 flux, P=0.212, Figure 1).
In this study we investigated the effect of pronounced weight loss induced by 
bariatric surgery on skeletal muscle mitochondrial function in morbidly obese 
subjects. ADP-stimulated (state 3) respiration increased significantly one year after 
bariatric surgery. Our data suggest that low skeletal muscle mitochondrial function 
in morbidly obese subjects is reversible by bariatric surgery-induced weight loss.
Skeletal muscle fat oxidation is negatively related to BMI,17 resulting in an increased 
muscle fat accumulation in obesity.9,18 This impaired lipid oxidation is associated 
with skeletal muscle insulin resistance and thus suggests a pathophysiological 
basis for obesity-related type 2 diabetes.9 In line with this notion, skeletal muscle 
mitochondria from obese type 2 diabetics displayed a reduced 
activity of the mitochondrial oxidative enzyme NADH-reductase, suggesting 
an impairment of mitochondrial function,5 which was confirmed by in vivo 
measurements.19 Furthermore, a detailed ex vivo analysis of mitochondrial 
function in permeabilized skeletal muscle fibres showed that the observed in 
vivo mitochondrial dysfunction in overweight type 2 diabetes (mean BMI; 28.9 
kg/m2) was associated with a decreased intrinsic mitochondrial capacity, i.e. 
ADP-stimulated (state 3) mitochondrial respiration corrected for mitochondrial 
density.3 Skeletal muscle mitochondrial state 3 respiration was also shown to be 
reduced in non-diabetic morbidly obese subjects eligible for bariatric surgery (mean 
BMI; 40 kg/m2) compared to lean controls.6 To observe whether obesity is causative 
for a decreased mitochondrial function, several reports have studied the effect 
of weight loss on skeletal muscle mitochondrial function, in both type 2 diabetic 
and nondiabetics. A diet-induced weight loss of 10.6 kg did not induce changes in 
mitochondrial NADH-reductase activity in nondiabetic obese subjects (mean BMI 
before weight loss; 33.4 kg/m2) 8 and one report even observed a decrease in 
mitochondrial cytochrome c oxidase activity after weight loss (12-17 kg weight 
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loss, initial BMI; 33-34 kg/m2).10 In contrast, after a more pronounced diet-induced 
weight loss in nondiabetics (13-32 kg weight loss, initial BMI; 33.8 kg/m2), an 
improved oxidative enzyme (succinate dehydrogenase) activity was observed.20 
Bariatric surgery results in pronounced weight loss and after Roux-en-Y-gastric-
bypass and bilio-pancreatic-diversion surgery (42-63 kg weight loss, mean initial 
BMI; 45.9-53.5 kg/m2) proteins associated with mitochondrial biogenesis (PGC1a 
and MFN2) were enhanced in skeletal muscle and related to improved insulin 
sensitivity as assessed by euglycemic-hyperinsulinaemic clamp. 12,13 Finally, in 
subjects with a ~50 kg weight loss after Roux-en-Y-gastric-bypass, skeletal muscle 
fatty acid oxidation (as assessed ex vivo with 14C-palmitate) did not change and 
was decreased compared to lean controls.21 However, the postoperative BMI was 
relatively high (36.5 kg/m2) compared to the current study (30 kg/m2).
In contrast to the abovementioned weight loss studies using biochemical assessments 
of mitochondrial enzyme activities to assess skeletal muscle mitochondrial function 
we here performed a detailed characterisation of mitochondrial function via ex 
vivo mitochondrial respiration in permeabilized muscle fibers. In this study we 
show that ADP-stimulated state 3 respiration increased after a mean 35-kg weight 
loss. The mitochondrial density (as assessed by mtDNA copy numbers) did not 
change after weight loss and therefore the observed improvement in mitochondrial 
respiration is an intrinsic mitochondrial characteristic. The improvement in muscle 
mitochondrial metabolism suggests that the observed weight loss could ‘restore’ 
obesity-induced impairments in skeletal muscle mitochondrial function. Further 
studies should elucidate the molecular and clinical changes associated with the 
increase skeletal muscle mitochondrial function. All included morbidly obese 
subjects were non-diabetic and plasma values (Table 2) for plasma insulin showed 
a nearly significant decrease (P=0.064). However, the homeostasis model for 
insulin resistance (HOMA-IR) did not change after weight loss (P=0.324). Although 
fasting insulin levels tended to be lower after weight loss (mean reduction; 28.6%) 
Characteristics Before After P-value
Age (years) 40 ± 9 41 ± 9 <0.001**
Body mass (kg) 126.71 ± 19.98 91.71 ± 18.81 <0.001**
BMI (kg/m2) 41.28 ± 4.75 29.82 ± 4.78 <0.001**
Body Fat % (BF%) 48.30 ± 5.21 34.11 ± 8.47 <0.001**
Fat Mass (kg) 61.45 ± 11.47 32.15 ± 11.79 <0.001**
Fat Free Mass (kg) 63.79 ± 13.02 58.98 ± 13.18 <0.001**
Table 1. Subject characteristics for two male and six female morbidly obese subjects before and after weight 
loss. *P<0.05, **P<0.001. BMI denotes Body Mass Index.
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Figure 1. Skeletal muscle fibre respirometry before (white bars) and after weight loss (black bars). A: Oxy-
gen consumption in the presence of endogenous substrates (state 2 respiration) was similar before and  after 
weight loss (P=0.310). B: ADP stimulated state 3 respiration upon a lipid substrate for complex I (malate, oc-
tanoyl-carnitine and glutamate (MOG) and complex I&II substrates (malate, octanoyl-carnitine, glutamate and 
succinate (MOGS)). C: State 3 respiration upon complex I substrates (malate, glutamate (MG)) and complex 
I&II substrates (malate, glutamate and succinate (MGS)). D: Leak (state 4) respiration obtained by addition of 
the ATP synthase inhibitor oligomycin. E: The relative contribution of state 4 to state 3 respiration (uncoupling 
ratio; UCR). F: Maximal respiration upon FCCP (state uncoupled). O2 flux shown: picomoles O2 consumption 
x seconds-1 x milligrams of tissue-1 x mtDNA x 106. Values shown are mean+S.E.M., n=8. *P<0.05
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further studies in morbidly obese diabetic populations are necessary to determine 
the effect of weight loss on skeletal muscle mitochondrial function and its relation 
to obesity-induced insulin resistance.
In summary, this study shows an increase in ex vivo skeletal muscle mitochondrial 
function in morbidly obese subjects one year after LAGB-induced weight loss. The 
level of weight loss in this study was higher than previous reports that did not 
observe differences in mitochondrial function after weight loss. Possibly, the very 
pronounced weight loss after bariatric surgery is necessary to recover mitochondrial 
function in morbid obesity. 
Table 2. Plasma values before and after weight loss. Values shown for two male and six female morbidly obese 
subjects before and after weight loss. *P<0.05, **P<0.001. TSH denotes Thyroid-Stimulating Hormone, FT4; 
Free Thyroxine, HOMA-IR; Homeostasis Model Assessment for Insulin Resistance, FFA; Free Fatty Acids.
Before After P-value
TSH (mU/mL) 2.03 ± 0.7 1.85 ± 0.4 0.341
FT4 (pmol/L) 13.53 ± 1.94 14.85 ± 1.43 0.009*
Glucose (mM) 4.86 ± 0.38 5.22 ± 1.04 0.199
Insulin (µU/mL) 25.44 ± 8.52 16.64 ± 5.16 0.064
HOMA-IR 4.90 ± 2.87 3.80 ± 1.13 0.324
FFA (µM) 588.34 ± 234.34 567.0 ± 283.43 0.750
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Increased oxygen consumption in human 
adipose tissue from the “brown adipose 
tissue” region
The contents of this chapter are submitted.
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Abstract
Background
Since the discovery of functional ‘brown adipose tissue (BAT)’ in adult man, there 
has been a renewed interest in the physiology of human BAT. Imaging studies 
using FDG-PET-CT have shown increased glucose uptake in adipose tissue regions 
assumed to be BAT in humans. However, so far this adipose tissue depot has 
not been characterized with respect to cellular and mitochondrial capacity. We 
here determine basal cellular oxygen consumption in human adipose tissue (AT) 
obtained from biopsies taken from the neck region, known to be FDG-PET-CT-
positive in previous studies. 
Methods
Mitochondrial respirometry in AT from the human BAT region was compared to 
the cellular respiration in subcutaneous white adipose tissue (WAT) taken from the 
neck of the same subject. 
Results
Adipose tissue from the human BAT region displayed increased cellular mitochondrial 
respiration, on average three times higher compared to subcutaneous WAT. The 
difference in basal respiration was much more pronounced than the previous 
reported 10-20% higher mitochondrial respiration in visceral adipose tissue, and 
illustrates that adipose tissue from human BAT region is a distinct adipose tissue 
depot with high mitochondrial capacity, similar to studies performed in rodents. 
Presence of uncoupling protein 1 (UCP-1) was confirmed by immunostaining as 
performed before. 
Conclusions
The results of this study suggest that human adipose tissue, taken from the region 
that was shown to be BAT-positive, can indeed be distinguished from subcutaneous 
WAT by the presence of UCP-1 and a significantly higher basal mitochondrial 
activity. Future studies should be directed to the further metabolic and bioenergetic 
characterization of this adipose tissue depot.
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Introduction
Since the discovery of functional brown adipose tissue (BAT) in adult man,1-3 there 
has been a vast increase in the scientific interest in the physiology of human BAT. 
PET-CT-studies (Positron-Emission-Tomography-and-Computed-Tomography) 
using the glucose tracer 18F-FDG (Fluorine-18-Fluoro-Deoxy-Glucose) have shown 
that cold-induced BAT activity is inversely related to body fat percentage and 
subjects with glucose uptake in BAT have higher thermogenesis.2,4,5 In addition, 
other studies have now indirectly measured in vivo BAT activity by means of 
different metabolic tracers.6,7 Collectively, these studies show increased metabolic 
activity in an anatomical region presumed to contain BAT in humans, located in the 
adipose tissue depot dorsal from the neck muscles. To date, adipose tissue in this 
region has not been characterized in great detail ex vivo, although some, mainly 
smaller studies have shown the presence of UCP1 and thermogenic preadipocytes 
in this adipose tissue.3,6,8 Very recently, we showed that adipocytes from this region 
can in fact be classified as beige fat cells; adipocytes genetically distinct from white 
and brown adipose tissue, but with the capacity to induce high levels of UCP1 
expression as in BAT.9
Here we had the unique opportunity to further characterize perioperative neck 
adipose tissue (AT) biopsies taken from the area that is now recognized as human 
“BAT” based on FDG-PET-CT positive glucose uptake and determined cellular 
respirometry in comparison to subcutaneous WAT from the neck from the same 
subject. We aimed to investigate if the AT from the BAT region can indeed be 
distinguished from normal WAT based on mitochondrial capacity. It is important 
to mention that mitochondrial respiration measurements in adipose tissue are 
not trivial, and only a few reports describe respiration measurements in human 
WAT.10,11 One of these studies shows that visceral adipose tissue is characterized 
by a ~10-20% higher mitochondrial respiration when compared to subcutaneous 
adipose tissue.10 In this study we measured cellular oxygen consumption in small 
adipose tissue samples and determined basal mitochondrial respiration and 
compared it to subcutaneous WAT taken from the same region. 
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Methods
Approval was obtained from the medical ethical committee of the Maastricht 
University Medical Centre. Thirteen patients indicated for thyroid gland surgery 
(indications provided in Table 1) gave informed consent for perioperative AT from 
the BAT region and WAT biopsies. All subjects were euthyroid to rule out influence 
of thyroid hormone (Table 2). 
Biopsy procedure
Previously successful UCP-1-positive adipose tissue biopsies were taken in the 
operative area involved in this type of surgery,2 and were here repeated. During 
surgery, both the surgeon (N.B.) and the researcher (G.V.) visually inspected the 
exposed operative area for presence of small ‘islands’ (±1-2 cm) of AT from the BAT 
region along the sternocleidomastoid muscle and more cranially along the thyroid 
gland. These adipose tissue depots are typically light brown/beige and have a firm 
consistency compared to WAT. When AT from the BAT region was recognized a 
biopsy of 0.5cm3 was taken together with 0.5cm3 of WAT. AT biopsies showed both 
univacuolar and multivacuolar adipocytes, characterized as white adipocytes and 
brown/beige adipocytes, respectively (Figure 1). 
Tissue processing
The tissue biopsies were directly placed in a tube with Phosphate-Buffer-Solution 
(PBS). Part of the AT from the BAT region and WAT (±10% of the total biopsy) 
were snap-frozen in isopentane and stored at -80ºC until further analysis. The 
remaining AT from the BAT region and WAT was placed in separate 2mL tubes 
with 10mM CaCl2 solution and Collagenase solution (PBS, 1% Bovine-Serum-
Albumin and 0.1% Collagenase-type-1) and then minced carefully. The tubes with 
minced AT from the BAT region and WAT were placed in a 37ºC shaking water 
bath (75 RPM) for 30 minutes and then centrifuged for 5 minutes at 1200 RPM 
at room temperature. Then the tubes with tissue were loosely shaken manually 
to disrupt the pellet and centrifuged again. Subsequently, the separated top layer 
of both the AT from the BAT region and WAT was pipetted off in two separate 
tubes with 2.3mL MiR05 respiration buffer (OROBOROS®, Innsbruck, Austria). The 
interphase was removed and the pellet was also added to the respiration buffer. 
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The respiration buffer containing the tissue was poured in two separate respiration 
chambers. Since the chamber volume is ±2mL, the remaining 0.3mL could be 
stored for determination of DNA and protein contents.
Respiration measurements
To determine oxygen consumption of AT from the BAT region and WAT, 
high-resolution respirometry was performed at 37°C by polarographic oxygen 
sensors in a two-chamber Oxygraph (OROBOROS® Instruments, Innsbruck, 
Austria). Basal respiration was measured once the tissue preparation was added 
Table 1. Indications and surgical therapy per included subject. MENIIA-syndrome indicates the Multiple En-
docrine Neoplasia syndrome type IIA, as was confirmed by genetic screening in subject families; a preventive, 
total thyroidectomy is indicated due to the high lifetime risk of developing thyroid gland cancer, mostly of the 
medullary type. Hyperparathyroidism indicates supraphysiological activity of the parathyroid gland, which 
is located adjacent to the thyroid gland itself. Parathyroidectomy indicates resection of the parathyroid gland, 
hemithyroidectomy indicates resection of the left/right half of the thyroid gland and total thyroidectomy indi-
cates a total resection of the thyroid gland as a whole.
Subject Indication Surgery
1 hyperparathyroidism parathyroidectomy
2 suspected thyroid gland mass hemithyroidectomy
3 suspected thyroid gland mass hemithyroidectomy
4 cyst left thyroid gland hemithyroidectomy
5 MENIIA-syndrome total thyroidectomy
6 suspected thyroid gland mass hemithyroidectomy
7 suspected thyroid gland mass hemithyroidectomy
8 MENIIA-syndrome total thyroidectomy
9 MENIIA-syndrome total thyroidectomy
10 struma hemithyroidectomy
11 hyperparathyroidism parathyroidectomy
12 struma hemithyroidectomy
13 suspected thyroid gland mass hemithyroidectomy
Table 2. Subject characteristics for eight male and five female subjects indicated for thyroid gland surgery. BMI 
denotes Body Mass Index; TSH denotes Thyroid-Stimulating Hormone (normal range 0.4-3.5 mU/L), FT4 
denotes plasma free thyroxine (normal range 4.0-18.0 pmol/L). 
Parameter Mean ± S.D. 
Male / Female 8 / 5
Age (years) 43 ± 19
Body mass (kg) 75.3 ± 14.9
BMI (kg/m2) 25.7 ± 4.9
TSH (mU/L) 2.1 ± 1.4
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to the respiration chamber without addition of exogenous substrates for about 
5-7 minutes. Once stable, mitochondrial respiration uncoupled from ATP synthesis 
(state 4) was determined via addition of the ATP synthase inhibitor oligomycin (1.0 
µL, 2mg/mL) for about 4-5 minutes. In addition, saturating concentrations (0.5 µL, 
10mM) of the chemical uncoupler FCCP (carbonyl-cyanide 4-(trifluoromethoxy)-
phenylhydrazone) were used to maximize oxygen flux, which allows for assessment 
of maximal mitochondrial capacity (state u respiration). Baseline respiration, state 
4 and state u were measured according to Hoeks et al. 12. After completion of 
respiration measurements, chamber-solutions were pipetted off and snap-frozen 
in liquid nitrogen and stored at -80ºC until further analysis. To account for 
any differences in the amount of collagenase-liberated cells added to the 
respiration chambers, the results were normalized to the DNA content measured 
spectrofluorometrically in the tissue preparations collected after measurement.13 All 
raw oxygen fluxes (expressed as picomoles O2 consumption x seconds
-1) for both 
WAT and AT from the BAT region were normalized for the DNA content measured 
in the cell suspensions derived from the oxygraph chambers (mg/mL). The DNA 
contents of these cell suspensions were not different for WAT and AT from BAT 
region (0.037±0.014 mg/mL vs. 0.043±0.021 mg/mL, P=0.108). Corrected oxygen 
fluxes are expressed as picomoles O2-consumption x seconds
-1 x (mg/mL)-1. All results 
showed similar trends and significance when oxygen fluxes were uncorrected, or 
when corrected for cellular protein content (results not shown). For comparison of 
the relative decrease in oxygen consumption upon the addition of oligomycin, the 
oligomycin-insensitive leak-state-4 respiration was divided by baseline respiration. 
This uncoupling ratio (UCR) was not different in AT from the BAT region compared 
to WAT (AT from the BAT region; 0.83±0.17, WAT; 0.79±0.20, P=0.501). The 
relative contribution of baseline respiration and state 4 respiration to the maximally 
uncoupled respiration, as calculated by baseline respiration or state 4 respiration 
divided by state u, was higher in AT from the BAT region but this did not reach 
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statistical significance (baseline / state u; AT from the BAT region; 0.83±0.21, WAT; 
0.70±0.33, P=0.292, state 4 / state u; AT from the BAT region; 0.68±0.17, WAT; 
0.54±0.26, P=0.122).  
Statistical analysis
Reported data was expressed as means ± SD. Statistical analyses were performed 
with PASW Statistics 18.0 for Mac OS X 10.6.4. WAT and BAT respiration 
measurements within subjects were compared using paired student’s t-tests. 
Comparisons between for age groups were made using unpaired student’s t-tests. 
A P-value below 0.05 was considered significant.
Figure 1. Histology of adipose tissue taken from the neck region during thyroid gland surgery. A: 18F-FDG-
PET-CT image of a lean young male subject after mild cold exposure. Black coloured areas indicate 18F-FDG 
glucose uptake. The red box indicates the anatomical adipose tissue area bordered by the medial edge of the 
sternocleidomastoid muscle, the lower edge of the thyroid gland and the jugulum. B: Hematoxylin-eosin (HE) 
section (5µm) of ‘beige’ coloured adipose tissue showing both univacuolar and multivacuolar adipocytes, 
characterized as white adipose tissue (WAT) and brown adipose tissue (BAT), respectively. C: Immunofluo-
rescence-staining for uncoupling-protein-1 (UCP-1) was positive in the multivacuolar adipocytes, confirming 
the presence of brown adipocytes. BAT denotes brown adipose tissue and WAT denotes white adipose tissue. 
Shown histology derives from a perioperative biopsy taken during a preventive total thyroidectomy for MENI-
IA-syndrome in a 19-year old male subject with a BMI of 21.9 kg/m2.
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Results
Presence of UCP-1 in adipose tissue biopsies 
In the adipose tissue biopsies from the BAT region additional immunofluorescence 
staining for the brown/beige adipose tissue-specific uncoupling protein 1 (UCP-1, 
Figure 1) was positive in the multivacuolar adipocytes, confirming the presence of 
brown/beige adipocytes in this adipose tissue depot. UCP-1 immunofluorescence 
for the WAT biopsies was completely negative, confirming no UCP-1 was present 
in the subcutaneous WAT biopsies.
Adipose tissue respirometry in AT from the BAT region compared to WAT 
Figure 2 shows the respiration levels of subcutaneous (WAT) and AT from the 
BAT region after normalization for DNA. Baseline respiration without addition of 
substrates was more than three times higher in AT from the BAT region compared 
to WAT (430.9±410.3 vs. 132.6±90.8 O2 flux, P=0.017). After addition of 
oligomycin to achieve leak state 4 respiration, oxygen fluxes for both AT from the 
BAT region and WAT significantly decreased (baseline vs. state 4; AT from the BAT 
region; 430.9±410.3 vs. 364.1±367.7 O2 flux, P=0.002, for WAT; 132.6±90.8 vs. 
104.6±78.6 O2 flux, P<0.001). Upon titration of FCCP oxygen fluxes increased 
to maximally uncoupled respiration (increase after FCCP; for AT from the BAT 
region; 364.1±367.7 to 491.1±423.8 O2 flux, P<0.001, for WAT; 104.6±78.6 to 
189.4±123.2 O2 flux, P=0.003).   
Age differences in respiration control ratios
The relative contribution of state 4 to state u respiration in WAT was significantly 
correlated to age (r2=0.466, P=0.010, Figure 3). For AT from the BAT region, the 
ratio of state 4 vs. state u for AT from the BAT region was significantly higher for 
subjects aged under 50 years (n=6) compared to older subjects (≥50 years, n=7, 
state 4/state u; 0.78±0.11 vs. 0.60±0.17 O2 flux, P=0.042, Figure 3).
Discussion
In this study oxygen consumption of adipose tissue from the human BAT region was 
compared to subcutaneous white adipose tissue, taken from the same anatomical 
region in the neck. The respiration in AT from the BAT region was on average 
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three times higher compared to subcutaneous WAT. These findings are in line with 
previous animal studies that show mitochondrial respiration in BAT is relatively 
high.14 
Recently detailed metabolic imaging studies on BAT activity in man using PET-CT 
have been performed.3,6,7 Upon cold exposure BAT oxidative metabolism as 
determined using 11C-acetate uptake increased ±150% whereas BAT perfusion 
using ((15O)H2O) increased ±200% and glucose uptake using 
18F-FDG increased 
±600%.6,7 The same parameters did not change significantly in WAT and baseline 
BAT oxygen uptake and perfusion were already doubled compared to WAT.6,7 Here 
we show that tissue taken from the region identified to be BAT already uses 300% 
more oxygen in the basal state and thus displays increased cellular respiration. This 
300% higher basal respiration is much higher than the previous reported 10-20% 
higher respiration in visceral adipose tissue compared to WAT, indicating that in 
humans AT from the BAT region is a very special metabolic active adipose tissue 
depot.10 It is important to note that biopsies from the neck region do not solely 
consist of brown or beige adipocytes, as may be the case in more homogenous BAT 
depots in rodents. Rather, as observed in Figure 1 and before,15 the adipose tissue 
Figure 2. Cellular respiration levels of human white adipose tissue (WAT) and adipose tissue (AT) taken 
from regions shown to contain brown adipose tissue (BAT). Oxygen consumption in WAT and AT from the 
BAT region shown for baseline respiration, oligomycin-insensitive leak state 4 respiration upon addition of 
oligomycin and maximally uncoupled state u respiration after addition of FCCP. All uncorrected oxygen 
fluxes (expressed as picomoles O2 consumption x seconds-1) for both AT from the BAT region and WAT were 
normalized for the DNA content in chamber solutions (mg/mL). Values shown are means+S.E.M. *P<0.05 for 
comparison between AT from the BAT region versus WAT baseline, oligomycin and FCCP-stimulated oxygen 
fluxes, respectively. #P<0.05, ##P<0.001 for comparison between baseline vs. oligomycin and oligomycin vs. 
FCCP-stimulated oxygen fluxes within tissues for WAT and AT from the BAT region.
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of this region is a mixture of white and UCP1-positive adipocytes, with a varying 
composition between subjects. This indicates that mitochondrial respiration in pure 
brown/beige adipocytes is likely much higher, and illustrates that strategies that are 
able to induce human brown/beige adipocytes may effectively result in an adipose 
tissue depot with a very high metabolic potential. Due to the limited amount of 
human tissue available and the amount needed for respiration studies, we could not 
perform a further characterization of the neck adipose tissue, such as mitochondrial 
content, which most likely explains the higher basal metabolic activity. More 
important, it is generally thought that the main component of heat production 
(extra oxygen consumption) in BAT derives from UCP1-mediated uncoupled 
‘leak’ respiration.16 The UCP-1 mediated thermogenesis needs to be activated by 
external stimuli, e.g. a sympathetically induced norepinephrine-release. Indeed, 
Figure 3. Relationships between subject age and mitochondrial respiration states of WAT and AT from the 
BAT region. A: Relationship between age and the relative contribution of state 4 leak respiration to maximally 
uncoupled state u respiration in WAT. B: Relationship between age and the relative contribution of state 4 
leak respiration to maximally uncoupled state u respiration in AT from the BAT region. C: Comparison of the 
relative contribution of state 4 leak respiration to maximally uncoupled respiration in AT from the BAT region 
from subjects below and above 50 years of age. *P<0.05
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in mice maximal respiration in BAT upon addition of NE increases 7-8 fold over 
basal respiration,17 and thus much higher than the FCCP-induced respiration in our 
study. Unfortunately, we were unable to determine NE-stimulated mitochondrial 
respiration in the isolated adipocytes from the BAT region: initial attempts were 
not successful, and the limited amount of this valuable human tissue available did 
not allow optimization of the procedure. In that respect, it is also known from 
rodent studies that BAT from several (e.g. 6-8 mice) animals needs to be pooled 
to render isolated brown adipocytes that respond to NE ex vivo. Nevertheless, the 
reported basal respiration levels in AT from the BAT region, together with the fact 
that this tissue is inhomogeneous with respect to white and brown/beige fat cell 
composition, suggest that true respiration in pure human brown/beige adipocytes 
may be high.
Interestingly, the contribution of state 4 to state u in AT from the BAT region 
was higher in subjects <50 years, which would be consistent with the notion that 
younger subjects are suggested to possess more active BAT.18 
Recent reports show that within WAT there is a subpopulation of cells that has the 
capacity to become thermogenic.19,20 These ‘beige’ or BRITE (brown-in-white) cells 
possess UCP-1 and are thus capable of thermogenesis upon sufficient stimulation.20 
Several studies have now reported the development of beige/BRITE cells upon 
diverse stimuli.20-23 In vitro cultured human preadipocytes that were isolated 
from adipose tissue taken in the same anatomical region as in this study became 
thermogenic adipocytes upon stimulation by both ß-agonists and proliferator-
activated-receptor-gamma (PPAR-gamma). Intriguingly, we recently showed that 
adipose tissue taken from the same area as in this report in fact is composed of such 
‘beige cells’, genetically distinct from white and brown fat.9 Respiration analysis of 
cloned beige cells showed that respiratory activity of these cells is comparable to 
classical brown adipocytes.9 These findings suggest that the amount of “brown 
adipose tissue” in humans may be inducible when activated by the right stimulators, 
consistent with our recent finding of induction of human “BAT” after weight loss.24 
In summary, we here show that the basal mitochondrial respiration of adipose tissue 
from the region characterized as “BAT” can be distinguished from subcutaneous 
adipose tissue by a ~300% higher mitochondrial respiration. This illustrates that AT 
from human BAT region is a distinct adipose tissue depot with high mitochondrial 
capacity. Future studies should be directed to further study the metabolic and 
bioenergetic aspects of this interesting depot. Cultured adipocytes from this AT 
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depot may be of specific interest to identify molecular targets that are able to 
stimulate this tissue. Such studies could play an important role in obesity treatment 
by inducing BAT activity and increasing energy expenditure.
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Chapter 7
-
Vagus nerve stimulated increased energy 
expenditure in relation to brown adipose 
tissue activity
The contents of this chapter are submitted.
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Abstract
Background
Human brown adipose tissue (BAT) activity is inversely related to obesity and 
positively related to energy expenditure. BAT is highly innervated and it is suggested 
the vagus nerve mediates peripheral signals to the central nervous system, there 
connecting to sympathetic nerves that innervate BAT. Vagus nerve stimulation 
(VNS) is used for refractory epilepsy, but is also reported to generate weight loss. 
We hypothesize VNS increases energy expenditure by stimulating BAT activity. 
Methods
Fifteen patients with stable VNS therapy (age: 45±10yrs; body mass index; 25.2±3.5 
kg/m2) were included. Ten subjects were measured twice, once with active and 
once with inactivated VNS. Five other subjects were measured twice, once with 
active VNS at room temperature and once with active VNS under cold exposure in 
order to determine maximal cold-induced BAT activity. 
Results
Basal metabolic rate (BMR) was significantly higher when VNS was turned on 
(mean change; +2.2%). Mean BAT activity was not significantly different between 
active VNS and inactive VNS (BAT SUVMean; 0.55±0.25 versus 0.67±0.46, P=0.619). 
However, the change in energy expenditure upon VNS intervention (On-Off) was 
significantly correlated to the change in BAT activity (r=0.935, P<0.001).
Conclusions
Activated VNS significantly increased energy expenditure. The observed change 
in energy expenditure was significantly related to the change in BAT activity. This 
suggests that the VNS-induced increase energy expenditure in humans is at least 
partly due to BAT activation. Chronic VNS might have a beneficial effect on the 
energy balance and play an important role in weight management. 
Vagus nerve stimulated energy expenditure in relation to brown adipose tissue activity 105
7
Introduction
Obesity results from an imbalance between energy intake and energy expenditure 
and most applied obesity therapies are focussed on decreasing energy intake.1 
However, in addition to a reduction in energy intake, increasing energy expenditure 
could be an effective means to prevent or treat obesity. In rodents, activated brown 
adipose tissue (BAT) is the main contributor to the regulated energy expenditure.2 
Here, during cold exposure BAT activation increases energy expenditure by 
producing heat (thermogenesis) to prevent hypothermia.2 Recently functional 
brown adipose tissue (BAT) was also shown in adult man by means of FDG-PET-
CT (18F-fluorodeoxyglucose positron-emission tomography and computed 
tomography).3,4 Interestingly, BAT activity was inversely correlated with body mass 
index (BMI) and body fat percentage (BF%).3,5 Moreover, subjects with active 
BAT show a significantly higher energy expenditure compared to subjects without 
BAT activity.5,6 This suggests BAT is related to the development of obesity and 
increasing BAT activity could be a new treatment modality for obesity. Rodent 
studies and histological analyses of human tissue samples have shown BAT is 
highly sympathetically innervated.7,8 Stimulation of sympathetic b-receptors on 
brown adipocytes was already suggested as a possible target for the treatment of 
obesity several years ago9. More recent studies report stimulation and suppression 
of BAT activity in rodents which is mediated through the vagus nerve.10,11 It is 
suggested the vagus nerve mediates peripheral signals to the central nervous 
system (CNS), which in turn connects to the sympathetic nerves that innervate 
BAT.11 Interestingly, electrical stimulation of the cervical part of the vagus nerve 
(vagus nerve stimulation (VNS)) generates weight loss in rodents.12,13 Weight loss 
was also reported as a secondary outcome of VNS in humans, where it is used to 
treat refractory epilepsy.14-19 The weight loss induced by VNS may be the result 
of increased energy expenditure through BAT stimulation. However, most human 
trials are primarily focused on the effect of VNS on epilepsy from a neurological 
viewpoint and to date no prospective study has investigated the effect of VNS 
on energy expenditure. Therefore, this study aims to define the relation between 
VNS energy expenditure and BAT activation in a patient cohort on chronic stable 
VNS therapy for refractory epilepsy. We hypothesize that VNS increases energy 
expenditure by stimulating BAT activity. 
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Methods
Approval for the study protocol was obtained from the ethics committee of the 
Maastricht University Medical Centre. The study was registered in the Clinical Trial 
Register under the ClinicalTrials.gov Identifier NCT01491282. Written informed 
consent was obtained from 15 patients on stable VNS therapy using the Vagus 
Nerve Stimulation Therapy System (VNS Therapy®, Cyberonics Inc., Houston, 
Texas, USA) for refractory epilepsy. All included subjects had stable therapy (i.e. no 
recent adjustments in VNS settings or epilepsy medication (Table 1) and were aged 
between 18 and 65 years. Exclusion criteria were daily epileptic seizures, pregnancy, 
ketogenic diet, mental retardation and psychological instability. 
Principle of vagus nerve stimulation
VNS is an approved procedure for refractory epilepsy patients. The therapeutic goal 
of VNS is a reduction in seizure frequency, seizure severity, and an improvement 
in general well-being. The VNS Therapy® System consists of a programmable 
pulse generator implanted subcutaneously at the level of the upper left chest. A 
helical bipolar electrode connected to the left vagus nerve transmits electric signals 
generated by the pulse generator. The stimulation parameters are adjusted via 
telemetric control to an optimal value for every individual patient. Standard starting 
parameters are: output current 0.25 mA, pulse width 250-500 msec, frequency 
30 Hz, On-period 30 sec, Off-period 5 min. If the effect is suboptimal, the output 
current is increased in steps of 0.25 mA to a maximum of 3 mA. The most common 
standard therapeutic setting is: output current 1-2 mA, pulse width 250 msec, 
frequency 30 Hz, On-period 30 sec, Off-period 5 min. A second option is the 
introduction of Rapid Cycling, where the On-period is 7 sec and the subsequent 
Off-period 20 sec. Patients responding to Rapid Cycling are thought to need this 
extra stimulation to acutely suppress an upcoming seizure in order to obtain a 
reduction in their seizure frequency. 
Study protocol
Energy expenditure was measured using indirect calorimetry and BAT activity was 
assessed by means of FDG-PET-CT during actual VNS and when VNS was inactivated. 
This was possible since the anticonvulsive effect of VNS is considered chronic and 
short-term inactivation does not lead to an acute increase in seizures. In addition, we 
compared BAT activity during VNS and during mild cold stimulation. The mild cold 
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intervention served as a control since it is known to activate BAT.3,5 Ideally, one would 
like to compare the effect of active/inactive VNS with and without cold exposure, 
which would result in four FDG-PET-CT measurements in each subject. However, 
due to ethical considerations a maximum of two FDG-PET-CT measurements was 
allowed. Therefore, ten patients were measured in thermoneutral (TN) conditions 
with active (VNS-On) and inactive VNS (VNS-Off) respectively. In addition, five 
subjects were measured with active VNS in TN conditions (VNS-TN) and during 
mild cold exposure (VNS-Cold) respectively (Table 2). Subjects were measured 
under fasted conditions (no food intake from 10 p.m. the night before, only water 
consumption was allowed) from 9 a.m. to 2 p.m. under supervision of a specialized 
research nurse (L.L.). VNS-On and VNS-Off took place on separate occasions 
within 14 days. During VNS-Off the system was inactivated (output current 0 mA, 
magnet function 0 mA) at 9:30 a.m. prior to the measurements. At the end of 
the test day (2:00 p.m.) the VNS system was re-activated. During VNS-Cold the 
settings of the VNS system were not adjusted. VNS-TN and VNS-Cold were also 
Table 1. Medication use per patient.
Subject Medication
1 carbamazepine, lamotrigine, lacosamide
2 carbamazepine, clonazepam
3 levetiracetam, oxcarbazepine, clobazam
4 carbamazepine, valproic acid, lamotrigine, lacosamide
5
lamictal, levetiracetam, calciumcarbonate, domperidon, paracetamol, folic acid, hydroxy-
chloroquin, bisacodyl, tramadol, zolpidem, pantoprazol, estradiol/norethisteron
6 gabapentine, clobazam, levetiracetam
7 levetiracetam,  carbamazepine, desogestrel
8 clorazepine, gabapentine, topiramate
9 oxcarbazepine, calcium supplements
10 carbamazepine, lacosamide, L-carnitene
11 clobazam, retigabine, lacosamide, sertralin, desogestrel
12 levetiracetam, lamotrigine, clemastine, cinnarizine, omeprazol
13 pipamperon, lacosamide, clobazam, carbamazepine, levetiracetam
14
clobazam, lamotrigine, gabapentin, carbamazepine, perindopril/indapamide, dipyridamol/
acetyl salicylic acid, bisoprolol, nifedipin, atorvastatin
15 fenytoin, clonazepam, oxcarbazepine
Chapter 7108
performed within a 14-day period. Body composition (body fat%, fat mass (FM), 
fat free mass (FFM)) was determined by dual x-ray absorptiometry (DXA, type 
Discovery A, Hologic, Bedford, MA, USA). 
During the experiments the subjects wore standardized clothing (socks 0.02 clo 
(clothing insulation factor), shirt 0.09 clo, sweatpants 0.28 clo, underwear 0.04 
clo, total clo factor 0.43 clo).20 A catheter was placed in the left antecubital vein 
for blood sampling during measurements and to inject 18F-Fluoro-Deoxy-Glucose 
(FDG) for FDG-PET-CT (for further detail on scanning protocol see below). Body 
core temperature was monitored by a telemetric pill that was orally ingested 
(CoreTemp, HQ Inc., Palmetto, FL, USA). iButtons were placed at 14 ISO-defined 
skin sites to measure skin temperatures.21 For comparison between proximal and 
distal body temperatures, the proximal skin temperature was defined as the mean 
of the iButtons placed on the chest, abdomen, shoulder and lower back. The distal 
skin temperature was defined as the mean of the iButtons placed on the wrist and 
foot. Next, subjects were placed in a semi-supine position on a nephrodialysis chair 
covered with a water-perfused mattress (necessary for the cold exposure protocol, 
see below) in a specially equipped tent (Colorado Altitude Training, Louisville, 
CO, USA) where energy expenditure was measured by indirect calorimetry using 
a ventilated hood system (Omnical, Maastricht Instruments BV, Maastricht, the 
Netherlands). Laser Doppler Flowmetry (PF5000; Perimed, Jarfalla, Sweden) was 
used to determine skin blood flow gradients dorsal of the medial malleolus and at 
the glabrous skin of the ventral hand thenar to monitor whether a subject was in 
its thermoneutral zone as reported.22 The VNS-On/Off (n=10) and VNS-TN (n=5) 
measurements were performed under thermoneutral conditions (average room 
temperature VNS-On; 24.9±0.8°C, VNS-Off; 25.2±1.0°C, VNS-TN; 25.2±0.9°C, 
P=0.7260). After the first hour of measuring under thermoneutral conditions 
(t0-t60) 10ml FDG was injected. After the second hour (t60-t120), FDG-PET-
CT imaging was performed to quantify metabolically active BAT. The scanning 
protocol, FDG activity (74 MBq) and data analysis were identical to our previous 
studies on BAT activity.5,23 During VNS-Cold a personal cooling protocol was 
used as described earlier in detail.5 In short, after measuring under thermoneutral 
conditions (t0-t30), the subject was cooled until they reported shivering. Upon the 
first signs of shivering the temperature was raised slightly (on average 2.3±0.6°C) to 
Vagus nerve stimulated energy expenditure in relation to brown adipose tissue activity 109
7
ensure only non-shivering thermogenesis (NST).5 After one hour of stable cooling 
situation (t30-t90), 10ml FDG was injected, followed by the second hour of cooling 
(t90-t150) and subsequent FDG-PET-CT imaging. 
FDG-PET-CT analysis
Tissue activity on FDG-PET-CT was expressed in standard uptake value (SUV; as 
calculated by uptake (kilobequerels per ml) per injected dose (kilobequerels) per 
patient weight (grams)) using the PMOD Biomedical Image Quantification tool 
(PMOD Technologies Ltd., Zurich, Switzerland). Tissue activity of each region was 
determined by the mean SUV uptake (SUVMean). For comparison, standard cube 
volumes-of-interest (VOIs) were placed in the tissue type studied: Brown Adipose 
Tissue (BAT), deltoid muscle (Deltoid), biceps muscle (Biceps), triceps muscle 
(Triceps), erector spinae muscle at the level of vertebrae C7 (C7), T8 (T8), and 
L3 (L3), the mean of all analyzed muscles (Muscle), subcutaneous white adipose 
tissue (WAT Sc), visceral white adipose tissue (WAT Visc), the liver (Liver) and the 
brain at the level of the cerebellum (Brain) (Figure 1). The volume of these three-
dimensional cubes was 1.33 cm3 (i.e. three consecutive slices of 0.44cm3 thickness). 
For BAT the placement of one cube in supraclavicular adipose tissue often interferes 
with adjacent muscle and hence the cube volume in BAT was composed of three 
separate slices of 1.0x1.0x0.44cm. When drawing the cubes, attention was paid 
to the Hounsfield Units (HU) on CT to define the specific tissue type and to avoid 
interference with adjacent tissue. For example, adipose tissue has a HU of -200 to -10 
and muscle 10 to 100. Finally, FDG-PET-CT imaging during the Off-measurement 
failed in one subject due to a critical image reconstruction error. Consequently, 
values shown are for nine subjects in the VNS-On/Off group and five subjects in 
the VNS-TN/Cold group.
Statistics
Reported data were expressed as means ±S.D. Statistical analyses were performed 
with PASW Statistics 18.0 for Mac OS X 10.6.4. Repeated measurements (VNS-On 
versus VNS-Off, and VNS-TN versus VNS-Cold) were compared using paired 
student’s t tests. Comparisons between groups (VNS-On/Off versus VNS-TN/
Cold) were made using one-way ANOVA with a post-hoc Bonferroni correction. A 
P-value below 0.05 was considered significant.
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Results
Subject characteristics
Ten male and five female patients with a mean age of 45±10 years and a mean 
Body Mass Index (BMI) of 25.2±3.5 kg/m2 that were (successfully) treated with 
VNS for refractory epilepsy were included (Table 1). VNS implantation was on 
average 59±19 months (range; 22-89 months) ago and all subjects did not have any 
recent adjustments in their VNS settings or medication (last adjustment >1 month 
ago, VNS output current; 1.58±0.55 mA, Table 2). Pre-VNS treatment body weight 
and BMI were retraceable for 11 subjects and were not significantly different from 
weight and BMI during the study (implant weight and BMI; 71.2±12.5 kg, 24.7±3.4 
kg/m2, current weight and BMI; 72.9±11.6 kg, 25.2±3.5 kg/m2, P=0.414). The 
subject characteristics were not different for the On/Off (n=10) versus the TN/
Cold group (n=5) (Table 2).  
Energy expenditure
Basal metabolic rate (BMR) decreased significantly when VNS was turned off 
(68.6±7.9 J/s versus 67.2±8.1 J/s, P=0.038, mean change; 2.2%, range; -3.1 to 
7.8%, Table 3, Figure 1). All but one subject decreased their BMR; the male subject 
with increased BMR was very restless during the Off-measurement due to personal 
affairs. Exclusion of this subject revealed energy expenditures of 68.6±7.9 J/s 
(VNS-On) and 66.6±8.31 J/s (VNS-Off)(P=0.005). The subject’s data remained 
included in the further presented analyses. 
Upon cold exposure BMR increased as compared to thermoneutral conditions (TN; 
68.2±1.5 J/s versus Cold; 75.1±7.7 J/s, P=0.107, Table 3). BMR in the VNS-TN group 
was similar to BMR in the VNS-On group (P=0.919).  
Core and skin temperatures
Body core and mean skin temperatures did not change significantly when VNS 
was turned off (core temperature; 37.0±0.3 ºC versus 36.9±0.4 ºC, mean 
skin temperature; 33.5±0.8 ºC versus 33.6±0.7 ºC, P=0.738, Table 2). When 
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skin temperatures were divided in proximal and distal zones 21, the distal skin 
temperature was significantly increased during the Off-measurement (31.7±1.6 ºC 
versus 33.0±1.7 ºC, P=0.016, Table 2). 
During cold exposure skin temperatures decreased significantly (TN: mean skin 
temperature; 33.2±0.4 ºC versus Cold: 29.0±0.8 ºC, P<0.001, Table 2).
Skin perfusion
Perfusion of the medial foot and ventral hand did not change during VNS (foot; 
8.2±3.9 Arbitrary Units (AU) versus 13.4±21.4 AU, P=0.396, hand; 54.5±35.3 
AU versus 81.7±70.5 AU, P=0.149, Table 3). Cold exposure significantly decreased 
hand but not foot perfusion (hand; 25.1±11.4 AU versus 6.0±1.4 AU, P=0.029, 
foot; 9.6±8.0 AU versus 6.8±4.4 AU, P=0.396, Table 3).
BAT activity and FDG uptake in other tissues
Figure 2 shows representative images of FDG-uptake on PET-CT in the studied 
groups. The mean SUV for BAT showed no statistical difference during VNS (BAT 
SUVMean; 0.55±0.25 versus 0.67±0.46, P=0.619, Table 2, Figure 3). In different 
muscles analyzed, the triceps muscle had a significantly increased FDG-uptake when 
VNS was turned off (Triceps SUVMean; 0.51±0.14 versus 0.70±0.16, P=0.024, Table 
Table 2. Subject characteristics for all subjects, the intervention group with Vagus Nerve Stimulator (VNS) On 
and Off (n=10) and for the group with VNS during thermoneutral (VNS-TN) conditions and cold exposure 
(VNS-Cold) (n=5). P-values shown for unpaired t-tests between VNS-On/Off and VNS-TN/Cold. *P<0.05
Characteristics Group VNS-On/Off VNS-TN/Cold P-value
n 15 10 5
Sex (Male/Female) 10 M / 5 F 4 M / 6 F 1 M / 4 F
Age (yrs) 45±10 42±10 49±8 0.203
Height (cm) 170±10.0 168.5±8.4 173±13 0.464
Mass (kg) 73.0±11.6 70.1±11.7 78.6±10.4 0.194
BMI (kg/m2) 25.2±3.5 24.6±3.0 26.6±4.4 0.316
Fat Free Mass (kg) 49.8±9.0 48.8±9.5 51.7±8.5 0.568
Fat Mass (kg) 21.9±6.4 20.4±5.3 25.0±8.0 0.199
Body Fat (%) 29.5±6.9 28.5±6.4 31.4±8.2 0.459
VNS output current (mA) 1.58±0.55 1.55±0.59 1.65±0.52 0.752
VNS implant time (months) 59±19 64±15 50±24 0.185
VNS implant mass (kg) 71.2±12.5 69.8±13.9 72.8±12.0 0.717
VNS implant BMI (kg/m2) 24.7±3.4 24.9±3.1 24.5±4.1 0.861
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3). However, for all muscles together there was no significant change in activity 
(Muscle SUVMean; 0.57±0.14 versus 0.65±0.11, P=0.100, Table 3). The FDG-uptake 
in the liver significantly increased during VNS (Liver SUVMean; 1.60±0.46 versus 
2.04±0.45, P=0.038, Table 3). After cold exposure, all subjects showed increased 
BAT activity (BAT SUVMean; 0.65±0.29 versus 3.40±1.63, P=0.012, Table 3, Figure 
3). Deltoid muscle activity was significantly decreased in the cold (Deltoid SUVMean; 
Table 3. Energy expenditure, core and skin temperatures, skin perfusion and Standard Uptake Values (SUVMean) 
for Brown Adipose Tissue (BAT), all muscles analyzed (Muscle), deltoid muscle (Deltoid), biceps muscle (Bi-
ceps), triceps muscle (Triceps), erector spinae muscle at the level of vertebrae C7 (C7), T8 (T8), L3 (L3), sub-
cutaneous white adipose tissue (WAT Sc), visceral white adipose tissue (WAT Visc), the liver (Liver) and the 
brain at the level of the cerebellum (Brain). AU denotes Arbitrary Units for skin perfusion. *P<0.05, **P<0.001
Parameter On Off P-value TN P-value
Energy expenditure (J/s) 68.6±7.9 67.2±8.1 0.038* 68.2±1.5 0.107
Core temperature (ºC) 37.0±0.3 36.9±0.4 0.738 36.9±0.2 0.877
Mean skin temperature (ºC) 33.5±0.8 33.6±0.7 0.686 33.2±0.4 <0.001**
Proximal skin temperature (ºC) 34.6±1.1 34.6±0.5 0.996 34.0±1.3 0.012*
Distal skin temperature (ºC) 31.7±1.6 33.0±1.7 0.016* 31.7±2.5 <0.001**
Perfusion Foot (AU) 8.2±3.9 13.4±21.4 0.396 9.6±8.0 0.553
Perfusion Hand (AU) 54.5±35.3 81.7±70.5 0.149 25.1±11.4 0.029*
SUVMean BAT 0.55±0.25 0.67±0.46 0.619 0.65±0.29 0.012*
SUVMean Muscle 0.57±0.14 0.65±0.11 0.100 0.78±0.14 0.012*
SUVMean Deltoid 0.57±0.16 0.62±0.10 0.281 0.74±0.11 0.031*
SUVMean Biceps 0.62±0.17 0.69±0.17 0.390 0.89±0.14 0.130
SUVMean Triceps 0.51±0.14 0.61±0.13 0.024* 0.70±0.16 0.260
SUVMean C7 0.62±0.22 0.66±0.13 0.572 0.85±0.23 0.209
SUVMean T8 0.63±0.12 0.72±0.10 0.081 0.79±0.16 0.475
SUVMean L3 0.46±0.15 0.60±0.16 0.057 0.75±0.29 0.389
SUVMean WAT Sc 0.19±0.09 0.24±0.08 0.194 0.24±0.09 0.742
SUVMean WAT Visc 0.36±0.16 0.55±0.30 0.111 0.47±0.13 0.881
SUVMean Liver 1.60±0.46 2.04±0.45 0.038* 2.44±0.41 0.405
SUVMean Brain 6.58±2.07 6.82±1.65 0.730 7.45±1.68 0.183
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0,74±0.11 versus 0.65±0.14, P=0.031, Table 3, Figure 3) and also activity for all 
muscles together decreased upon cold exposure (Muscle SUVMean; 0.78±0.14 versus 
0.72±0.14, P=0.012, Table 3, Figure 3).
Correlations 
Energy expenditure during VNS-On and VNS-Off measurements was not related 
to BAT activity, activity of other tissue (Muscle, WAT), skin perfusion, core and 
skin temperatures or any other study parameter. However, the change in energy 
expenditure upon VNS intervention (from VNS-On to VNS-Off) was positively 
Figure 1. Basal metabolic rate (BMR) during 
active and inactive VNS in relation to BAT 
activity. A. Individual responses upon VNS 
intervention. Notice all but one (marked 
line) subjects decreased energy expenditure 
upon deactivation of the VNS (subject that 
increased energy expenditure also described 
in Results section). B. Mean group BMR upon 
VNS intervention. C. The change in energy 
expenditure (∆ Energy Expenditure) upon 
VNS intervention (On/Off) correlated to the 
change in BAT activity. One subject (open dot) 
showed a high increase in energy expenditure 
upon VNS intervention. This subject was 
confirmed as an statistical outlier in the expo-
nential growth equation shown and therefore 
excluded from the equation. Values shown are 
means+S.E.M. Significance shown for paired 
t-test in VNS intervention group consisting of 
4 males and six females. *P<0.05 
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correlated to the change in BAT activity (exponential curve fitting, r=0.935, 
P<0.001, Figure 1). VNS output current was not related to BAT activity or energy 
expenditure.
Discussion
This study shows that even short-term intervention of VNS therapy by turning 
off the VNS for only several hours significantly decreased energy expenditure 
in a cohort of treatment-stable VNS patients. In addition, the change in energy 
expenditure upon inactivation of VNS was significantly related to a change in BAT 
activity. Therefore, VNS possibly positively influences energy balance by increasing 
energy expenditure through involvement of BAT in humans. This might induce 
weight loss and as such VNS might contribute to weight management. 
Comparison with previous studies on VNS therapy
An effect of VNS on metabolism had already been suggested by the authors of a 
Figure 2. FDG-PET-CT images of intervention group and cold exposed subjects. Transaxial and coronal CT, 
PET and PET-CT fused images of VNS-On and VNS-Off from a subject in the VNS-On/Off group and images 
from a subject in the VNS-TN/Cold group during thermoneutral conditions (TN) and cold exposure (Cold). 
PET-CT image shown with and without Volume-Of-Interest (VOI) cubes for determination of activity. The 
white line in the coronal image indicates the transaxial slice shown above.
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Figure 3. FDG-PET-CT activity of different tissue types upon VNS intervention. SUVMean (Standard Uptake 
Value)w values for Brown Adipose Tissue (BAT), all muscle (Muscle), deltoid muscle (Deltoid), biceps muscle 
(Biceps), triceps muscle (Triceps), erector spinae muscle at the level of vertebrae C7 (C7), T8 (T8), L3 (L3), 
subcutaneous white adipose tissue (WAT Sc), visceral white adipose tissue (WAT Visc), the liver (Liver) and 
the brain at the level of the cerebellum (Brain). A. Comparison of activity during VNS-On and VNS-Off. B. 
Comparison of activity between VNS-On, VNS-Off and VNS-Cold. Values shown are mean+S.E.M. *P<0.05 
for paired t-tests between VNS-On and VNS-Off. #P<0.05 for one-way ANOVA with post-hoc Bonferroni 
correction between VNS-On, VNS-Off and VNS-Cold.
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brief report where weight loss was observed in 17/27 patients with VNS for epilepsy 
(2002).17 Pardo et al. studied a morbidly obese cohort of 14 VNS patients treated 
for depression (weight 91±27 kg, BMI 43±5 kg/m2) with VNS settings comparable 
to the present study (>24 months VNS implant, Output current; 0.25-1.5 mA, 
Freq; 30 Hz, Pulse; 500-μs, On-period; 30s, Off-period; 5 min, VNS current study; 
Output current; 1.58±0.55 mA, Freq; 30±0 Hz, Pulse; 266.7±64.5 μs, On-period; 
23.9±10.5s, Off-period; 3.7±2.1min) and observed a significant BMI-related weight 
loss after VNS therapy.16 The short-term intervention in normal weight subjects 
in the current study already showed a significantly increased energy expenditure 
during VNS. Although the mean difference in BMR was small, the weight loss 
observed by Pardo et al. in morbidly obese subjects suggests long-term VNS results 
in increased energy expenditure and could be important in weight maintenance. 
Another study reported 33 obese patients (BMI; 30.1±3.6 kg/m2) receiving VNS 
for depression and investigated the response to a food stimulus upon active and 
inactive VNS.19 Short-term VNS intervention significantly altered food craving. 
Duration of VNS intervention was not specified, but seems to have taken place 
within several hours, which is similar to the present study.19 
All currently published data on the effect of VNS on metabolism in humans 
are retrospective. However, in animals a prospective study in overfed minipigs 
undergoing bilateral VNS (implanted 5 cm above the diaphragm) with stimulation 
parameters comparable to our study (VNS minipigs; Output current; 2mA, Freq; 
30Hz, Pulse; 500-μs, On-period; 30 s, Off-period; 5 min, VNS current study; see 
above) has revealed that weight gain was prevented in the VNS-treated minipigs 
and not in controls.24  VNS in these minipigs significantly decreased food intake, 
especially carbohydrate consumption (‘sweet craving’) as assessed by the respiratory 
quotient (RQ).24 In the present study we did not observe a difference in RQ after 
VNS intervention (RQ On; 0.82±0.03 versus RQ Off; 0.82±0.04, P=0.8774) and 
the mean RQ of ±0.8 confirms the prescribed overnight fast preceeding the BMR 
measurments. However, possibly RQ does show a significant difference in man 
when studying VNS in longer time periods, for example before and after VNS 
implantation.
Finally, in a study on the effect of VNS on metabolism Sobocki et al. used a 
crossover design in pigs with activation and de-activation, each in a 4-week period 
and found that VNS prevented weight gain but did not affect metabolic rate as 
assessed by indirect calorimetry.25 However, metabolic rate was determined under 
general anesthesia, which probably affected BMR measurements. Possibly BMR 
did change under awake conditions, as was observed in the current report, which 
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would explain the significant differences in weight gain observed by Sobocki et al.
Mechanism of VNS increased energy expenditure
Possible mechanisms by which VNS affects energy expenditure have been suggested 
in several studies. From an anatomical viewpoint, it is interesting to note that the 
majority of fibers present within the vagus nerve are afferent fibres (74%) and only 
a minority (26%) are efferent, indicating that the vagus nerve is both an afferent 
nerve and efferent nerve as well.26 
Within the hypothalamus, several areas have been studied in respect to the 
regulation of energy balance. The hypothalamic arcuate nucleus receives vagus 
signals and projects them to the paraventricular nucleus (PVN), which in turn signals 
to the sympathetic nervous system and to the thyroid axis.27 Vagotomy blocks 
these responses and alters energy homeostasis.27 In the ventromedial nucleus of 
the hypothalamus (VMH), an area adjacent to the PVN, both parasympathetic 
and sympathetic neurons are present, and it is suggested the VMH regulates the 
‘balance’ between sympathetic and parasympathetic nerve activities. Therefore, 
VMH stimulation may affect sympathetic mechanisms. Electrical stimulation of 
the VMH increased energy expenditure and decreased RQ in rats, suggesting 
an increased fat oxidation.28 Indeed, VMH stimulation, but not PVN-stimulation, 
increases norepinephrine turnover and thermogenesis in interscapular BAT in rats, 
and this effect is completely inhibited by blockage of sympathetic ganglions.29,30 
Interestingly, vagotomy has been demonstrated to decrease NE-turnover in BAT,11 
suggesting that vagus signals may influence BAT thermogenesis. In the present 
study, we observed a significant change in energy expenditure that was related 
to changes in the activity in BAT and not to changes in any of the other tissues 
that we have measured. Despite the fact that mean BAT activity did not increase 
upon VNS, the change in BAT activity explained a large part of the change in 
energy expenditure. To our opinion, this suggests at least part of the effect of VNS 
intervention on energy expenditure can be explained by BAT activity. 
BAT presence and activity in refractory epilepsy
Since BAT activity is reported to decrease with age31 and can be affected by several 
pathophysiological conditions,32 we considered the possibility of reduced presence of 
BAT in (these) patients with refractory epilepsy. Therefore, we investigated maximal 
BAT activity in VNS patients after mild cold exposure. Mild cold exposure is known 
to induce BAT activation in 100% of lean young subjects (age; 24.3±3.6 years, BMI; 
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23.2±1.2 kg/m2) and to be related to BMR and cold-induced thermogenesis.3,5,6 
Despite their relatively high mean age (49±8 years) but comparable BMI (26.6±4.4 
kg/m2), cold-induced BAT activity was present in all five patients. After mild 
cold stimulation BAT presence and activity were significantly higher than under 
TN conditions (VNS-Cold; BAT SUVMean 3.40±1.63 versus VNS-TN; BAT SUVMean 
0.65±0.29, P=0.012), but slightly lower as compared to previously studied healthy 
young subjects (Age; 23±2 years, BMI; 23.1±1.7 kg/m2, BAT SUVMean; 7.19±2.09 
versus current study BAT SUVMean; 3.40±1.63, P=0.010, Vosselman et al., 
unpublished data). We believe this may be attributed to an age-related decrease 
in BAT activity.31 Therefore, BAT thus does not appear to be decreased in patients 
with refractory epilepsy.
Effect of VNS on muscle and liver metabolism
In contrast to the significant increase in energy expenditure that was related to 
BAT activity, we observed a decrease in liver and triceps muscle glucose uptake 
on FDG-PET-CT upon VNS. This is in line with the observation that in rodents 
cannabinoid receptor 1 (CB1) antagonism is known to induce sympathetic nervous 
system (SNS) activity and increase energy expenditure and BAT activity (as 
measured by the temperature in BAT itself), but not liver and muscle activity.33 In 
addition, CB1 antagonism also induces fatty acid oxidation,34 which could be the 
effect of the increased BAT activation, since BAT was recently shown to be able to 
combust lipids.35 Moreover, it is known increased fatty acid oxidation can lead to 
inhibition of glucose uptake (the so-called Randle effect),36 which would decrease 
activity on FDG-PET-CT imaging since this selectively depicts glucose uptake. 
Therefore, although there is a decrease in FDG-PET-CT-activity in liver and muscle, 
there could still be increased metabolism upon VNS in these tissues resulting from 
increased fatty acid oxidation. This would be consistent with an increase in BAT 
fatty acid oxidation and increased energy expenditure upon VNS. However, in this 
study we were not able to study fatty acid metabolism since FDG-PET-CT is a 
glucose tracer. In this regard, more research focused on liver and muscle function 
as well as fatty acid metabolism upon VNS is needed. 
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Conclusion
In summary, the present study demonstrates for the first time that VNS is 
accompanied by an increase in whole body energy expenditure, compared to 
short term deactivation of VNS. Moreover, the increase in energy expenditure was 
positively related to the change in BAT activity. This suggests that the VNS-induced 
increase in energy expenditure is at least in part due to changes in BAT activity. 
Therefore, chronic VNS might have a beneficial effect on energy balance and 
might play a role in weight management. However, the observed mean differences 
in energy expenditure are small, probably to a large extent because of the short 
duration of the intervention, and future, long-term, prospective studies should 
point out if VNS has a clinically and therapeutically significant effect on whole 
body metabolism. In addition, detailed metabolic imaging studies should assess the 
effect of VNS on BAT and other tissues in order to identify new possible targets in 
the treatment of obesity.  
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Introduction
Heat production in brown adipose tissue (BAT) serves a vital function in small 
mammals and human newborns in order to prevent hypothermia upon cold exposure.1 
Recently, BAT has also been shown to be present and active in adult humans.2-4 In 
this thesis, we studied the physiology of human BAT from a cellular level to effects 
on whole body metabolism. In man, BAT activity is negatively related to the degree 
of obesity and positively related to energy expenditure.2,4,5 Since obesity results 
from a disturbed energy balance, it is interesting to study the physiology of human 
BAT. To increase the understanding of the function of human BAT in obesity, in 
this thesis we investigated BAT activity under pathophysiological conditions in 
morbid obesity. Moreover, we investigated if human BAT can be stimulated upon 
electrical nerve stimulation. In this final chapter the main findings of this thesis will 
be discussed and interpreted. In addition, possible clinical implications and future 
directions of BAT in treating disease will be addressed.
Measuring human BAT on a cellular level
In Chapter 6 for the first time cellular oxygen consumption was determined in 
surgical biopsies taken from the adipose tissue region known to contain BAT in 
man. When we compared the cellular oxygen consumption in this adipose tissue 
depot to subcutaneous WAT, we strikingly found a ~300% higher level of oxygen 
consumption in adipose tissue derived from the BAT region. These results thus 
confirmed the presence of metabolically active BAT in the neck. However, our 
measurements were performed under baseline conditions without the addition of 
stimuli to increase BAT activity as cold or sympathetic nervous stimuli. In pure 
brown adipocytes derived from mice it was possible to increase BAT activity 
700-800% upon NE-infusion.6 Therefore, possibly the addition of adequate 
stimuli can even further increase human BAT activity. On top of that, adipose 
tissue from the BAT region does not solely consists of ‘pure’ brown adipocytes, 
but rather seems to be a mixture of several types of adipocytes that vary in size in 
mitochondrial content.7 To characterize these cells, it is important to understand 
the origin of BAT. Classically, it was thought that during development preadipocytes 
irreversibly differentiated into the brown or white phenotype, without being able 
to change throughout life. However, histological observations suggested there also 
were adipocytes that could ‘turn into one another’.8 In 2007 it was shown that 
addition of rosiglitazone (an antidiabetic drug known to stimulate the transcription 
factor PPAR-gamma) to cultured WAT-precursors induced the development of 
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UCP1-containing thermogenic cells.9 These cells were genetically different from 
BAT, but able to generate a similar level of thermogenesis, and therefore baptized 
BRITE (brown-in-white) adipocytes. At the same time, the discovery of PRDM16, 
a zinc-finger protein, gave more insight into the development of BAT,10 and later it 
was shown PRDM16 and BMP7 are crucial factors in the development of BAT.11,12 
Following the experiments tracing back the development of BAT, it was also 
shown that prostaglandins (more specific COX-2, which is interestingly inhibited 
by most anti-inflammatory drugs) were able to induce ‘browning’.13,14 Moreover, 
preadipocytes capable of becoming thermogenic were also shown to reside in 
skeletal muscle and a specific exercise-induced myokine capable of ‘browning’ was 
discovered; irisin.15-17 In man, in cultured biopsies taken from the same adipose 
tissue region as described in Chapter 6, it was shown to be possible to reproduce 
the rosiglitazone-effect in vitro.18 In addition, molecular characterization was done 
on human adipose tissue biopsies from our center, similar to the biopsies studied in 
Chapter 6. The results showed the adipocytes present in these tissue depots could 
be characterized as ‘beige’ adipose tissue, and not BAT.19 Full-grown beige cells 
were shown to form stable adipose tissue depots after transplantation in mice.19 In 
the murine beige cells studied cellular respirometry was performed, similar to the 
method we used in Chapter 6. Murine beige cells showed a significantly higher 
baseline respiration and oligomycin-insensitive uncoupled respiration compared 
to WAT.19 Also, under unstimulated conditions, the contribution of uncoupled 
respiration to baseline respiration was 78% for BAT and 60% for beige cells, 
suggesting UCP1-induced mitochondrial uncoupling is already present without 
any stimulus. In Chapter 6, in our biopsies from the human BAT region, 83% 
of baseline respiration was derived from uncoupled respiration, which confirms 
findings observed in mammals.19 Unfortunately, we were not able to determine the 
effect of, for example, ß-adrenergic stimulation on human biopsies, which has been 
shown to dramatically increase cellular respiration up to 700-800% of baseline.6
Measuring human BAT on a whole body level
The development of new imaging techniques as FDG-PET-CT allowed for detailed 
study of metabolically active tissue activity and in a prospective study under 
controlled conditions of cold exposure from our lab FDG-PET-CT showed active 
BAT in lean young adults in 2009.2 Other reports that were published in the same 
period also showed consistent BAT activity in humans and therefore a renewed 
curiosity for investigating BAT in man was born.3,4,20 In this thesis, in Chapter 3 we 
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found that - in combination with our group of previously studied lean subjects2 - 
BAT activity was robustly related to BMI and percentage body fat. This suggests 
a sufficient level of BAT activity could play an important role in maintaining body 
weight. Chronic overfeeding previously showed large interindividual differences in 
weight gain, which were suggested to possibly result from undetermined genetic 
factors.21 Interestingly, genetic polymorphisms in the UCP1-gene have been shown 
to be related to the energy balance (Chapter 2). Moreover, recently it was shown 
that polymorphisms of the UCP1-gene and the gene for the β3-adrenergic receptor, 
both essential for BAT thermogenesis (Chapter 2), may be associated with visceral 
fat accumulation during life.22 Therefore, genetic factors predisposing for low BAT 
activity could possibly contribute to the development of obesity.
Intermezzo
Measuring human BAT using an individualized cooling protocol
From a methodological point of view, it is important to note that in Chapter 3 and 4 
all morbidly obese subjects underwent an individualized cooling protocol in order 
to induce maximal NST. To adequately measure BAT activity using FDG-PET-CT 
imaging presently only cold exposure is known to be able to consistently promote 
FDG-uptake in BAT. However, the cold exposure needs to be strong enough 
to induce maximal NST, but low enough to prevent ST. This is necessary, since 
shivering in skeletal muscle would increase the muscular FDG-uptake and possibly 
decrease uptake in BAT resulting in an inadequate interpretation of BAT activity. 
Most dedicated studies on BAT activity use a standardized cooling level for each 
studied subject, not taking into account the interindividual differences in body 
composition and thermoneutral zone.23 When exposed to a similar level of cold 
exposure, a morbidly obese subject will experience a less intensive cold stimulus 
compared to a lean subject through their difference in subcutaneous adipose 
tissue insulation.24 Therefore, we cooled each subject until shivering occurred. 
Subsequently, we gradually increased temperature until shivering just stopped 
(Figure 1). This protocol ensures a maximal level of NST, and thus a maximal level 
of BAT activity for each subject, independent of body composition. 
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In Chapter 4, we observed an increase in BAT activity after a ~35 kg weight loss. 
In addition, subjects with absent BAT activity during morbid obesity showed 
recruitment of BAT activity upon weight loss in regions that contained BAT 
activity in the lean subjects studied before. These results suggest BAT is rather a 
consequence than a cause of obesity. After observing an increase in BAT activity 
after weight loss in Chapter 4, we also studied the effect of weight loss on skeletal 
muscle mitochondrial uncoupling in Chapter 5. Although we did not observe a 
change in skeletal muscle mitochondrial uncoupling, the ADP-stimulated skeletal 
muscle metabolism did significantly increase after weight loss. This suggests that 
in addition to ‘restoring’ the level of BAT activity, sufficient weight loss is also able 
to recover obesity-associated impaired skeletal muscle metabolism. Although we 
were unable to define the molecular mechanism responsible for the observed 
recruitment of BAT, the observed BAT recruitment provides hopeful evidence for 
future studies targeting BAT recruitment in man. Moreover, as discussed in Chapter 
2, in addition to obesity other studies have now shown relations between a low BAT 
Figure 1. Individualized cooling protocol. During two hours of cooling maximal non-shivering thermogenesis 
(NST) is induced to stimulate brown adipose tissue (BAT) activity. Temperatures shown are room temperatures 
in degrees Celsius.
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activity and type 2 diabetes, hepatosteatosis and hypothyroidism, which even more 
emphasizes that BAT seems to be play a relevant role in both human physiology 
and pathophysiology.
Intermezzo
Functional imaging of human BAT
The first evidence of functional BAT in humans was shown using FDG-PET-CT 
imaging studies (Figure 2).25,26 Prospective studies using controlled cold exposure 
to maximize NST in BAT showed high levels of BAT activity which was related 
to body composition and energy expenditure.2-4 However, FDG-PET-CT relies on 
the concept of cellular uptake of radioactive glucose (FDG). Interestingly, detailed 
studies in the mammalian brown adipocyte have shown the main fuel for BAT 
are free fatty acids (FFAs).1 Glucose uptake in BAT is considered low (~10%) 
and is suggested to function in order to maintain the mitochondrial membrane 
proton gradient or to be part of the glycerol component of FFAs (Chapter 2). 
Estimations made from glucose clearance rates in dynamic FDG-PET-CT studies, 
assuming glucose contributes for 10% and FFAs 90% to BAT metabolism, suggest 
a metabolic contribution for BAT of  ~5% to the basal metabolic rate.27 However, 
this is a rough estimation since FFA-metabolism was not quantified and most 
Figure 2. FDG-PET-CT-scan of morbidly obese subject. The PET-image (A) shows FDG uptake supraclav-
icular on the right (1) and left (2) side. The combined PET-CT (B) shows activity in adipose tissue (3 and 4), 
confirming this is BAT.
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FFA-lipolysis in BAT is performed intracellular.1 Therefore, although FDG-PET-CT 
has facilitated the discovery of functional BAT in man, ideally one would like to use 
other metabolic tracers to determine the metabolic capacity of BAT. Interestingly, 
fatty acid uptake in human BAT was recently shown by using the fatty acid tracer 
18FTHA.28 During cold exposure, fatty acid uptake in BAT was significantly higher 
compared to WAT. The increase in energy expenditure in this report was high (up 
to 80%), but possibly resulted to a large extent from skeletal muscle shivering 
due to the strong cold exposure in this study. Another study showed a significant 
relation between BAT perfusion (as measured by radioactive labelled water ((15O)
H2O) and whole-body energy expenditure,
29 confirming the relation found using 
FDG,2 but unfortunately did not allow for determination of the contribution of 
BAT to NST. The most recent dedicated report measured oxygen consumption in 
BAT during cold exposure by dynamic oxygen (15O) PET imaging, a possibly very 
adequate marker for BAT metabolism.30 Remarkably, the authors conclude the 
contribution of BAT is only ~1% of the basal metabolic rate, much lower than 
reported above (~5%). However, the cooling period in this study was very short 
(20 min), whereas previously it was shown maximal NST is not generated until 
at least 60-80 minutes of cold exposure.31 In summary, no robust estimation of 
the contribution of BAT to the human energy balance has been shown yet, but 
prospective studies using adequate tracers and cooling methods can potentially 
determine the metabolic value of BAT in man. 
Stimulating BAT in man 
The above-discussed results suggest human BAT recruitment is possible and future 
studies should point out the effect of stimulating BAT differentiation in-vivo and 
implanting in-vitro developed tissue grafts. At this moment the most powerful 
and reproducible physiological stimulator of BAT is cold exposure, which increases 
sympathetic nervous system activity that is suggested to ß-adrenergically induce 
mitochondrial uncoupling in BAT (Chapter 2). In 1985, it was found that the 
ß-agonist ephedrine could not induce BAT activity in humans.32,33 However, the 
available methods for the assessment of BAT activity were limited to measuring 
tissue temperature with thermoprobes and therefore this experiment was recently 
repeated in combination with FDG-PET-CT studies.34 Although increased heart 
rate, blood pressure and energy expenditure showed the SNS was already clearly 
activated by a relatively high dose of ephedrine (1.0 mg/kg), BAT remained inactive 
in subjects that possessed active BAT upon cold exposure.34 A comparable study 
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using isoprenaline to induce ß-adrenergic activation also did not show BAT activity.35 
However, a high level of systemic ephedrine infusion (2.5 mg/kg) indeed induced 
BAT activity in lean but not obese subjects.36 Nonetheless, the BAT activity was 
low compared to cold-induced BAT activity and the high heart rate (~75 BPM) 
and increased blood pressure (~160 mm/Hg) that are accompanied with such high 
levels of ephedrine should not be underestimated. Therefore, possibly mimicking 
the effect of cold exposure on BAT could be performed by direct peripheral or 
central nervous stimulation (CNS). Interestingly, in 1989 electrical stimulation 
of the ventromedial hypothalamus (VMH) in the CNS of rats showed increased 
norepinephrine (NE) turnover in BAT in rats.37 This suggests electrical stimulus could 
possibly induce BAT activity in man. In practice, electrical stimulation of the CNS 
by vagus nerve stimulation (VNS) is performed in refractory epilepsy patients.38 
VNS decreases seizure frequency, possibly due to alterations in central nervous 
system activity.38 However, the exact mechanism of action of VNS is not known 
yet. Interestingly, VNS treatment has been reported to be associated with weight 
loss.39,40 Animal studies have also shown significant weight loss, associated with a 
decreased food intake.41-43 Based on this literature, in Chapter 7 we investigated the 
effect of VNS on energy expenditure and BAT activity in a treatment stable cohort 
of refractory epilepsy patients. Strikingly, we found that a short-term deactivation 
(~4 hours) already significantly decreased energy expenditure, which suggests 
VNS indeed increases energy expenditure and thus promote weight loss. On top 
of that, we observed a relation between the change in energy expenditure upon 
VNS and the change in BAT activity as observed by FDG-PET-CT. Although mean 
BAT activity did not change significantly upon the short period of deactivation, 
this shows that the increase in energy expenditure upon VNS could be facilitated 
by changes in BAT activity. All studied patients with refractory epilepsy showed 
increased BAT activity upon cold exposure, suggesting potentially high levels of 
active BAT could be induced by VNS. Therefore, the results described in Chapter 
7 justify a prospective study that observes VNS before and after implantation to 
unravel the long-term effect of VNS on BAT activity. Subsequently, the effect of 
VNS could be studied in diseases other than refractory epilepsy associated with 
low BAT activity. In addition, possibly direct sympathetic stimulation could provide 
a more direct induction of BAT activity. However, electrical sympathetic nervous 
system stimulation has never been performed and animal studies should be done 
first. In addition, other mechanisms to alter BAT activity should be studied, since 
VNS is an invasive surgical procedure with unknown long-term effects.
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Does BAT matter?
In the sections above, we discussed the high metabolism of human BAT under 
ex-vivo conditions and the large differences in human BAT activity in vivo in the 
context of the energy balance. On top of that, this thesis showed VNS increased 
energy expenditure, which could partly be explained by changes in BAT activity. 
Together, these results suggest human BAT could be of significant physiological 
value. To be able to estimate the actual contribution of human BAT to human 
energy expenditure, several assumptions can be made based on the results of this 
thesis. In Chapter 7, the basal metabolic rate (BMR) decreased significantly when 
VNS was turned off, with a mean change of 2.2% up to a maximum of 7.8%. After 
weight loss, BAT-positive morbidly obese subjects showed a mean NST of 13.7% 
(Chapter 4) compared to a mean NST of 2.4% in BAT-negative subjects. Therefore 
it is very likely that a large part of the ~10% difference in NST between BAT-positive 
and BAT-negative subjects was induced by active BAT. This again corresponds with 
the previous suggestion that NST in BAT could increase energy expenditure in man 
by ~5-20% of BMR.27 However, the static FDG-PET-CT imaging used in this thesis 
is not able to directly measure the metabolic activity of BAT, but recent dynamic 
imaging studies using FDG and other metabolic tracers have suggested BAT activity 
contributes up to 1-4.5% of BMR.3,30,44 BMR accounts for 55-65% to the total daily 
energy expenditure,27 which would make the contribution of BAT ~2.5% (~5% of 
BMR = ~2.5% of total daily energy expenditure) of the total daily energy expenditure 
(Figure 3). In summary, the results obtained in this thesis show, in combination with 
other reports, human BAT is related to human energy expenditure. Future studies 
should unravel methods to induce high levels of human BAT activity comparable to 
observations in rodents. In addition, possibly BAT metabolism could be positively 
altered in pathophysiological conditions that are accompanied with disturbed BAT 
activity, which would open the door for using BAT activation as a therapeutic tool 
in medicine.
Concluding remarks and future directions
Since Conrad Gesner in 1551 first described BAT as a tissue type he could not clearly 
classify as adipose tissue or muscle, the knowledge on BAT dramatically increased 
throughout the centuries. Especially in the last decades extensive information has 
emerged from rodent studies that investigated BAT into great detail.1 In this thesis 
BAT activity was shown to be strongly and inversely related to obesity, suggesting 
BAT is important in the pathophysiology of overweight. Moreover, possessing active 
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BAT was affiliated with a significantly higher level of NST. This is highly interesting, 
since NST is a relevant component of the human energy balance and thus low NST 
and low BAT could be risk factors for developing overweight.  Furthermore, this 
thesis shows that high levels of weight loss that radically change body composition 
are accompanied with an increase in BAT activity. This is important since it shows 
that low BAT activity is a consequence of obesity rather than a cause. The observed 
BAT recruitment upon weight loss provides hope for therapeutic options to stimulate 
BAT activity when low or absent. Therefore, possibly increasing or maintaining 
sufficient BAT activity could be beneficial for health. Future studies targeting BAT 
activity in obese patients could point out if stimulating BAT could be used to treat 
obesity and other diseases associated with low BAT activity. In addition, in this 
thesis human BAT was studied on a cellular level in order to give more insight in 
the metabolic value of human BAT. It is very likely the human ‘BAT’ as studied in 
Chapter 6 is ‘beige’, which provides a strong potential for a therapeutic increase 
in thermogenic cells in man since culturing and transplantation of beige cells was 
shown to be successful in rodents. If the successful transplantation of beige depots 
performed in mice could also be executed in man, this would provide a therapy for 
Figure 3. Estimation of the contribution of human BAT to total daily energy expenditure based on the results 
obtained from this thesis. Possibly, future studies targeting the factors shown in the cloud depicted in the mid-
dle could increase the contribution of human BAT.
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increasing BAT in man. Finally, this thesis investigated the possibility of stimulating 
BAT by electrical vagus nerve stimulation (VNS). VNS was shown to significantly 
increase energy expenditure, which could partly be explained by changes in BAT 
activity. Further research on the effect of VNS on energy expenditure and BAT 
activity could point out if VNS has a clinically and therapeutically significant effect 
on the energy balance.
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Summary of results
The number of people suffering from obesity and its associated comorbidities is 
rapidly increasing and therefore it is necessary to find a therapy for this global 
health problem. Here, in the last decade the interest in brown adipose tissue (BAT) 
has increased since BAT stimulation might serve a role in the treatment of obesity. 
Naturally, BAT has the ability to produce heat when a subject is exposed to a cold 
environment. When BAT could be stimulated to produce heat, the body’s energy 
expenditure increases and with a similar energy intake this could lead to weight loss. 
The activity of human BAT can be visualized by using FDG-PET-CT scans. This is an 
advanced scanning technique that depicts the uptake of radioactive glucose (FDG; 
2-deoxy-2-18F-fluoro-D-glucose) by means of PET-CT scanning (PET-CT; positron-
emission-tomography-and-computed-tomography). In this thesis, FDG-PET-CT 
was used to measure human BAT activity. This thesis describes studies on human 
BAT activity in three specific groups of patients. The first group of patients was 
suffering from morbid obesity, an amount of overweight that causes high health 
risks. Therefore, these patients underwent laparoscopic adjustable gastric banding 
(LAGB) surgery to restrict food intake and to induce weight loss. BAT activity was 
measured before and one year after surgery in Chapter 3 and 4. In Chapter 6 
we studied the activity of human brown and white adipocytes in a second group 
of patients that underwent thyroid gland surgery. We here took biopsies of 
adipose tissue in the areas that previously showed BAT activity on FDG-PET-CT 
scans. Finally, in Chapter 7 we studied patients with a vagus nerve stimulator for 
medically refractory epilepsy. In these patients we observed the effect of vagus 
nerve stimulation on energy expenditure en BAT activity. 
The review in Chapter 2 showed that BAT is present and active in humans and 
possibly serves an important physiological role. Moreover, from a clinical point 
of view the relation between BAT activity and energy expenditure suggests the 
stimulation of BAT activity might be a new therapeutic target to treat obesity. 
Furthermore, evidence from in vivo and in vitro studies showed that altered 
BAT activity could also be relevant in the pathophysiology of the metabolic 
syndrome (type 2 diabetes, dyslipidemia, hepatosteatosis), thyroid disease, 
pheochromocytoma, cancer cachexia, hibernoma and the immune system. Based 
on the literature available, therapeutic suggestions are made to stimulate BAT by 
cold, insulin, the central nervous system, bile acids and gut hormones. A summary 
is provided of molecular studies that show possibilities for the development of 
de novo BAT derived from other types of adipocytes or their progenitors. Finally, 
Summary 143
S
targets for future studies on the role of BAT in disease are discussed. In Chapter 3 we 
studied BAT activity in morbidly obese subjects and showed that - in combination 
with our previous findings in lean subjects - BAT activity was strongly and inversely 
related to body mass index (BMI) and body fat percentage (BF%). The morbidly 
obese subjects showed no BAT activity (BAT-negative) or lower BAT activity 
compared to lean subjects (BAT-positive). There was a significantly lower increase 
in energy expenditure upon cold exposure (non-shivering thermogenesis (NST)) in 
BAT-negative compared to BAT-positive subjects. This is important, since it may 
indicate that BAT is involved in human energy expenditure upon cold exposure. 
To unravel the observed low BAT activity in obesity in Chapter 3, we studied a 
group of morbidly obese patients selected for bariatric surgery in Chapter 4. In 
this group, we investigated the effect of weight loss induced by bariatric surgery 
and found an increased BAT activity after weight loss. Strikingly, after weight loss 
BAT became active in regions that were BAT-negative before weight loss, showing 
for the first time recruitment of BAT in man. Again, after weight loss BAT-positive 
subjects had a significantly higher level of NST compared to BAT-negative subjects. 
These findings BAT could be important in weight management in obesity. Most 
dedicated studies on BAT activity show BAT becomes active after cold exposure 
and suggest an important contribution of BAT to non-shivering thermogenesis 
(NST).6 Interestingly, in man NST has also been associated with skeletal muscle 
mitochondrial uncoupling.7 Therefore, we investigated the effect of weight loss 
induced by bariatric surgery on skeletal muscle metabolism in Chapter 5. Our results 
show the level of skeletal muscle mitochondrial uncoupling remains unaffected by 
weight loss induced by bariatric surgery. This is in line with previous reports that 
did not show changes in skeletal muscle metabolism after diet-induced weight loss. 
However, in Chapter 5 we showed skeletal muscle mitochondrial ADP-dependent 
state 3 respiration significantly increased after high levels of weight loss as observed 
after bariatric surgery. This suggests that, in addition to a beneficial effect on BAT 
activity and NST, bariatric surgery positively affects skeletal muscle metabolism but 
not thermogenesis. 
Both studies performed in Chapter 3 and 4 used FDG-PET-CT imaging to 
non-invasively quantify BAT activity. In Chapter 6, we determined cellular oxygen 
consumption in human adipose tissue obtained from the neck region that is known 
to be FDG-PET-CT-positive for BAT. Strikingly, in these tissue biopsies we observed 
an on average three times higher cellular mitochondrial respiration compared 
to subcutaneous white adipose tissue (WAT) from the same subject, measured 
under unstimulated conditions. These results show that adipose tissue from the 
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human BAT region has an increased metabolism even without external stimuli. To 
therapeutically induce BAT activity, in Chapter 7 we explored the effect of vagus 
nerve stimulation on BAT activity in refractory epilepsy patients. Our results show 
that during active VNS there is a significantly increased energy expenditure. The 
observed increase in energy expenditure upon VNS was related to the change in 
BAT activity, suggesting the effect of VNS on energy expenditure is partly due to 
changes in BAT activity. 
In the last years the knowledge on human BAT has strongly expanded. In this thesis, 
human BAT activity was studied and we observed a relation between BAT activity 
and obesity. This suggests low BAT activity could be important in the development 
of obesity. Fortunately, BAT activity increases after weight loss and therefore BAT 
could possibly be meaningful in weight management and health. Future studies 
aiming for increasing human BAT activity could possibly provide new options for 
the treatment of obesity.
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Dutch summary
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Samenvatting
Bruin vet is bekend sinds 1551 toen de Zwitserse bioloog Conrad Gessner bij het 
ontleden van marmotten een weefsel vond dat hij “noch als vet, noch als vlees” 
beschreef. In de eeuwen daarna werd er steeds meer bekend over bruin vet en in 
1972 volgde de eerste gedetailleerde anatomische omschrijving van menselijk bruin 
vet. Bruin vet zit bij volwassenen rond de grote vaten en spieren in de hals, boven 
het sleutelbeen, langs de wervelkolom en rond de nieren. 
Bruin vet verschilt duidelijk van wit vet; de witte vetcel heeft de capaciteit om 
overtollige energie vast te houden en bestaat met name uit een grote vacuole 
(blaas) waarin vetzuren worden opgeslagen voor gebruik in tijden van energietekort. 
Wanneer er sprake is van een overmatige hoeveelheid wit vet spreken we van 
overgewicht of obesitas. De bruine vetcel heeft een cytoplasma (celvloeistof) met 
daarin een grote hoeveelheid mitochondriën (energiecentrale) en bevat meerdere 
kleine vacuoles (blaasjes) gevuld met vetdruppels. De mitochondriën in bruine 
vetcellen zijn donker gekleurd en geven bruin vet zijn karakteristieke kleur, die in de 
praktijk varieert van karamelkleurig tot bruin/donkerrood. Naast een kleurverschil 
zijn er een aantal belangrijke eigenschappen die bruin vet onderscheiden van wit 
vet. De functie van bruin vet is het belangrijkste verschil met wit vet. Het is inmiddels 
aanvaard dat bruin vet energie gebruikt om warmte te produceren, in tegenstelling 
tot wit vet dat vooral functioneert als opslag van energie. Bruin vet kan die warmte 
produceren door een uniek proces dat plaats vindt in het mitochondrium van de 
bruine vetcel. Dit proces heet mitochondriële ontkoppeling, mogelijk gemaakt door 
het ontkoppelingseiwit 1 (uncoupling protein 1 (UCP1)). Tijdens de mitochondriële 
ontkoppeling in de bruine vetcel wordt warmte geproduceerd uit energie die in 
andere cellen gebruikt zou worden als bouwstof voor het lichaam. In de bruine 
vetcel wordt deze energie niet als bouwstof benut, maar gebruikt om het lichaam 
te verwarmen in een koude omgeving. Ten slotte is bruin vet ten opzichte van wit 
vet zeer goed doorbloed en heeft een rijke sympatische zenuwvoorziening. 
Omdat overgewicht een steeds grotere rol speelt in onze samenleving is de 
interesse in het functioneren van bruin vet de laatste jaren toegenomen. Hierbij 
wordt met name gedacht aan een rol voor bruin vet stimulatie als behandeling van 
overgewicht. Als bruin vet wordt gestimuleerd tot warmteproductie wordt er meer 
energie gebruikt door het lichaam; bij een onveranderd eetpatroon zou dat kunnen 
zorgen voor gewichtsverlies.
De activiteit van bruin vet kan bij de mens zichtbaar worden gemaakt door bij 
milde koude een FDG-PET-CT scan te maken. FDG-PET-CT is een geavanceerde 
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scantechniek, waarbij radioactieve glucose (suiker) wordt ingespoten. De stofnaam 
voor deze radioactieve glucose is FDG (2-deoxy-2-18F-fluoro-D-glucose), 
waarbij PET-CT (positron-emission-tomography-and-computed-tomography) de 
scantechniek is om de locatie in het lichaam van het opgenomen FDG af te beelden. 
Deze techniek hebben we gebruikt om de activiteit van bruin vet te meten. Dit 
proefschrift bevat studies naar de activiteit van bruin vet in gezonde proefpersonen 
en patiënten met een bepaald ziektebeeld. In dit proefschrift worden de resultaten 
beschreven van onderzoeken gedaan bij drie groepen patiënten. De eerste groep 
patiënten had ernstig overgewicht (morbide obesitas), waarbij er zoveel overgewicht 
was dat er sprake was van een groot gezondheidsgevaar. Daarom werd bij deze 
patiënten operatief een maagband geplaatst om te zorgen voor een beperking 
in voedselinname om af te vallen. De activiteit van bruin vet bij deze patiënten 
wordt voor de operatie en een jaar na de operatie beschreven in hoofdstuk 3 en 
4. In hoofdstuk 6 onderzochten we bij een tweede groep patiënten de activiteit 
van bruine en witte vetcellen, afgenomen op plekken in de hals waar in eerdere 
onderzoeken op de FDG-PET-CT scan bruin vet activiteit werd gezien. We hadden 
bij deze patiënten de mogelijkheid om biopten (stukjes weefsel) van bruin en wit 
vet te nemen omdat ze een schildklieroperatie ondergingen. Daarbij is het nodig 
spieren en vet in de hals bloot te leggen om de schildklier goed te kunnen zien; 
daardoor hadden we de mogelijkheid om bruin en wit vet biopten te nemen in 
het operatiegebied. Als laatste wordt in hoofdstuk 7 de derde onderzoeksgroep 
beschreven met patiënten die een elektrische nervus vagus zenuwstimulator 
hebben om epilepsie te behandelen. Wij onderzochten bij deze patiënten of 
zenuwstimulatie bruin vet kan activeren. Bruin vet activiteit werd met FDG-PET-CT 
scans gemeten nadat de stimulator aan en uit stond. 
In dit proefschrift wordt in hoofdstuk 2 een literatuur overzicht gegeven van eerdere 
klinisch georiënteerde onderzoeken naar bruin vet in de mens. De belangrijkste 
uitkomsten zijn: bruin vet activiteit laat een positief verband zien met de toename 
van energieverbruik in een koude omgeving en bruin vet activiteit is negatief 
gerelateerd aan van overgewicht. Daarnaast zijn er aanwijzingen dat bruin vet 
activiteit een rol speelt bij ziektes als type 2 diabetes, vetstofwisselingsstoornissen, 
vervette lever, schildklierziekten, kanker en afwijkingen in het immuunsysteem. 
Bruin vet zou mogelijk gestimuleerd worden door langere tijd in een koude 
omgeving te verblijven, door de zenuwen die bruin vet activeren elektrisch of met 
medicatie te stimuleren of door hormonen toe te dienen die de activiteit van bruin 
vet in cel- en dierstudies verhoogden. Hoofdstuk 3 beschrijft ons onderzoek naar 
bruin vet activiteit bij obesitas. De resultaten laten zien dat bruin vet activiteit zeer 
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laag of zelfs afwezig is bij morbide obesitas en bij de patiënten zonder bruin vet 
activiteit was de warmteproductie in een koude omgeving veel lager. Nadat deze 
patiënten een maagbandoperatie hadden ondergaan en gemiddeld 36 kilogram 
slanker werden onderzochten wij opnieuw de bruin vet activiteit in hoofdstuk 4. 
Een jaar na de operatie werd er bij vier van de tien patiënten een toename van bruin 
vet activiteit gezien. Dit suggereert dat ernstig overgewicht de koude activatie van 
bruin vet voorkomt. Mogelijk kan dit van invloed zijn op het handhaven van een 
gezond gewicht. Naast bruin vet kan ook spierweefsel zijn mitochondriën voor 
ontkoppeling gebruiken. Hierdoor wordt in een koude omgeving in de spieren 
warmte geproduceerd zonder te rillen. In hoofdstuk 5 onderzochten wij in dezelfde 
morbide obese patiënten de functie van mitochondriën in spiervezels voor en 
na gewichtsverlies door een maagbandoperatie. De resultaten laten zien dat de 
activiteit van spiermitochondriën toenam na gewichtsverlies. Dit suggereert dat 
gewichtsverlies door middel van een maagbandoperatie naast een toename in 
bruin vet activiteit ook de spierstofwisseling kan laten toenemen. In hoofdstuk 6 
werd het zuurstofverbruik van bruine vetcellen vergeleken met witte vetcellen van 
dezelfde persoon. Deze cellen waren afkomstig uit het halsgebied van patiënten 
die een schildklieroperatie ondergingen. Er werd weefsel afgenomen uit het gebied 
dat in de onderzoeken in hoofdstuk 3 en 4 op de FDG-PET-CT scan bruin vet 
activiteit liet zien. Omdat er nog eerder onderzoek is gedaan naar de activiteit 
van menselijke bruin vetcellen moest er een protocol worden ontwikkeld, waarbij 
gebruik gemaakt werd van de kennis opgedaan uit onderzoek naar menselijk wit 
vet en bruin vet van dieren. De resultaten die werden verkregen met gebruik van 
het ontwikkelde protocol laten zien dat het zuurstofverbruik in vetweefsel dat werd 
afgenomen op de plek die eerder op FDG-PET-CT scans bruin vet activiteit liet zien 
drie keer hoger is dan in witte vetcellen van dezelfde patiënt. Dit suggereert dat de 
menselijke bruine vetcel buiten het lichaam, zonder de toevoeging van stoffen die 
bruin vet activeren, een hoge stofwisseling heeft. Hoofdstuk 7 beschrijft het effect 
van zenuwstimulatie (nervus vagus stimulatie) op het energieverbruik en bruin vet 
activiteit. Er werd gezien dat zenuwstimulatie het energieverbruik verhoogt. Ook 
was er een relatie tussen de stijging van het energiegebruik en bruin vet activiteit. 
De stijging in energieverbruik kan dus voor een deel veroorzaakt zijn door bruin vet 
activatie.
Sinds Conrad Gessner in 1551 bruin vet voor het eerst beschreef is de kennis over 
bruin vet sterk toegenomen. Met name in de afgelopen jaren is er veel informatie 
verkregen uit studies in cellen en muismodellen. In dit proefschrift werd bruin vet 
activiteit onderzocht in de mens en werd er een relatie gezien tussen bruin vet 
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activiteit en overgewicht. Dit suggereert dat een lage bruin vet activiteit belangrijk 
kan zijn bij het ontstaan en in stand blijven van overgewicht. Mogelijk is een lage 
bruin vet activiteit een risicofactor voor het ontwikkelen van overgewicht. Gelukkig 
is er een toename in bruin vet activiteit na fors gewichtsverlies. Behandelingen 
gericht op het stimuleren van bruin vet kunnen mogelijk een positieve invloed 
hebben op het gewicht en de gezondheid. Toekomstige studies gericht op het 
verhogen van bruin vet activiteit bij mensen met overgewicht kunnen mogelijk 
nieuwe opties geven voor het behandelen van obesitas. 
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Ik kan het bijna niet bevatten, maar het is zover; het proefschrift is af en de datum 
staat vast! In 2009 begon ik als verse drs. aan de uitdaging die er uiteindelijk toe zal 
leiden dat die –s er binnenkort af gesnoept kan worden! Het was echter nooit zover 
gekomen als ik niet zo ontzettend veel hulp, steun en motivatie had ontvangen 
van alle mensen om mij heen. Bij dezen wil ik daarom iedereen waarmee ik heb 
mogen samenwerken ontzettend bedanken voor de mooie tijd en gezelligheid die 
het mogelijk maakten deze enorme berg werk te verzetten. 
Allereerst wil ik alle patiënten bedanken die tijd vrijmaakten om mee te doen aan 
onze studies. Bedankt voor alle bezoeken, uren in de kou, spierpijn en donatie van 
biopten ten behoeve van de wetenschap. Een aantal van u heb ik mogen volgen in 
uw periode van gewichtsverlies na de operatie. Hier was het indrukwekkend om te 
zien hoe sociale levens weer opbloeien en mensen opeens weer midden in het leven 
staan doordat het overgewicht afneemt. Hoewel bruin vet daar soms ver weg van 
lijkt te staan, ligt hier voor mij wel de basis van mijn motivatie om iedere dag mijn 
werk te doen. Of het nu overgewicht betreft of zoveel andere ziektebeelden die 
ik tegenwoordig voorbij zie komen; uiteindelijk gaat het erom mensen te helpen.
Een speciaal woord van dank wil ik aan iedereen geven die mijn promotie mogelijk 
heeft gemaakt, met in het bijzonder de volgende mensen:
Mijn co-promotores Nicole, Wouter en mijn promotor Patrick. Nicole, toen ik in 
mijn derde studiejaar op jouw kamer kwam om te vragen hoe je nu het best chirurg 
kunt worden heb je mij direct onder je vleugels genomen. Direct kon ik beginnen 
met wetenschappelijk onderzoek, waarbij jouw altijd aanwezige enthousiasme zo 
aanstekelijk heeft gewerkt dat het uiteindelijk tot dit proefschrift heeft geleid. Ik wil 
je voor zoveel zaken bedanken; het ‘regelen’ van een baan direct na mijn studie, 
het ‘lobbyen’ bij alle disciplines om onze studies mogelijk te maken, de begeleiding 
tijdens mijn klinische en wetenschappelijk werk en je interesse in mijn persoonlijke 
leven. Ik kon altijd bij je terecht, waarvoor ik je zeer dankbaar ben. De manier 
waarop jij je werk doet en altijd opgewekt bent dwingt bij mij groot respect af en 
dienen als voorbeeld. Wouter, toen ik als ‘clinicus’ met het bruin vet onderzoek bij 
jou begon was mijn kijk op een promotietraject een stuk anders dan nu. Ik wilde 
zo snel mogelijk zo veel mogelijk doen en had daarbij absoluut geen tijd om te 
wachten op wat dan ook. Gelukkig wist jij me ervan te overtuigen dat er meer is 
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dan het ‘doel’, namelijk de weg waarop je je bevindt. Hierbij denk ik met een warm 
gevoel terug aan een avond in een Londense pub waar we dit onderwerp onder het 
genot van vele pints en ales hebben besproken. De discussie vlamde op naar een 
niveau waarop Boris het uiteindelijk met een echte oorvijg van jou moest bekopen, 
maar die avond is mij wel duidelijk geworden waar jij het over had; althans, dat 
denk ik nu tenminste.. Ik wil je bedanken voor je geduld en een vorm van dagelijkse 
begeleiding waarbij je altijd tijd hebt voor je promovendi. Ook naast het werk op 
de universiteit waren we altijd welkom om mee te varen op de Iguana en in jullie 
prachtige huis wijntjes te komen drinken. Onder mijn optimisme is de boot de eerste 
keer onder de Kennedybrug door gevaren, een mooi moment dat ik niet vergeet. 
Patrick, ik heb diep respect voor jouw gedrevenheid als wetenschapper. Toen ik 
je leerde kennen kon ik niet geloven dat iemand zo snel zo veel kan bereiken. 
Die snelheid heb ik mogen ervaren wanneer ik een manuscript na maanden werk 
opstuurde en enkele uren later, meestal in de avond, terug kreeg met gedetailleerd 
en gevat commentaar. Door jouw hulp is mijn promotie vlot verlopen en ik hoop 
dat je me inmiddels vergeeft dat ik tijdens ons wielrentochtje een keer net iets 
sneller boven was dan jij. Ik wil je bedanken voor je begeleiding als promotor.
I would like to thank professor Van Baak, professor Daanen, professor Hesselink, 
professor Mottaghy and dr. Virtanen for critically evaluating this thesis. Dr. Virtanen, 
thank you for travelling from Finland to be part of the corona.
De basis van promotieonderzoek werd gelegd tijdens mijn WESP-stage in een 
verlaten cardiolab op de derde verdieping. Maartje, Ruben, Kirsten en Dennis, 
bedankt dat jullie me toe hebben gelaten in jullie domein en ik hoop in de toekomst 
nog eens met jullie te mogen samenwerken.
Na mijn studie werd ik door Nicole Bouvy en Sven van Helden aangenomen 
als arts-assistent bariatrische chirurgie. Sven, bedankt voor de mogelijkheid te 
assisteren op de OK en klinische ervaring op te doen. Ik hoor veel goede verhalen 
uit Zwolle en hoop je op 7 juni weer te mogen spreken om bij te praten. In deze tijd 
deelde ik een kamer met Stella, Magda en Bart. Stella en Magda, als echte dames 
ondersteunden jullie Bart en mij tijdens als ons gemopper. Bedankt voor de leuke 
gesprekken, adviezen en het geweldig lekkere Italiaanse avondje in Ceramique. 
Bart, Bartje, BPPvW, we hebben veel plezier gehad op deze ‘inpandige’ kamer 
zonder direct daglicht en op de poli waar jij net als ik vaak met enigszins aparte 
patiënten te maken had. Ik heb respect voor je gedrevenheid en was altijd zeer 
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onder de indruk als je weer een A4-tje op de muur plakte met je zoveelste artikel 
in korte tijd. Ik wil je bedanken voor je kameraadschap en hoop ook binnenkort 
op jouw feestje te mogen komen. Tijdens mijn werk op de polikliniek chirurgie 
werd ik altijd gesteund door Bernadette en consorten, bedankt voor jullie hulp en 
flexibiliteit. Ook wil ik Evelien Goldberg in het bijzonder bedanken, als secretaresse 
van Nicole was jij altijd bereid te helpen, veel dank daarvoor. In deze periode kon 
ik door de hulp van Johanne Bloemen op maandagavond plaats nemen als adviseur 
in de commissie onderzoeksbeleid (COB). Daar zag ik alle subsidieaanvragen en 
hoogleraar-aanstellingen voorbijkomen, een zeer leerzame en leuke functie. Ilske, 
Marco, Margreet en professor Ten Cate, bedankt voor de leuke tijd in de COB. Toen 
ik na een tijdje had gezien hoe zo’n aanvraag in zijn werk ging besloot ik er zelf 
een te schrijven. Na een pittige presentatieronde kwam Ilske uiteindelijk met het 
goede nieuws dat ik een van de drie (uit dertig!) gehonoreerde  aanvragen kreeg. 
Nog steeds ben ik enorm blij met deze Kootstra Talent Fellowship die het voor 
mij mogelijk maakte fulltime wetenschappelijk onderzoek te gaan doen. Johanne, 
zonder jouw tip in de COB plaats te nemen was dit misschien nooit mogelijk 
geweest, bedankt daarvoor.
Vanaf november 2010 werd ik voortaan gestationeerd op kamer 2.306 bij de afdeling 
Humane Biologie. Op deze afdeling heb ik als klinisch georiënteerd arts geleerd hoe 
basaal wetenschappelijk onderzoek in zijn werk gaat en gezien met hoeveel precisie 
en geduld dit gepaard gaat. Zonder de hulp van bijna iedereen op deze afdeling was 
dit proefschrift nooit tot stand gekomen. In het bijzonder wil ik de mensen bedanken 
waar ik direct mee samen heb gewerkt. Mijn kamergenootjes Madeleen, Bianca en 
Hasibe, bedankt voor jullie verdraagzaamheid. Als enige mannelijke kamergenoot 
heb ik een mooie en gezellige tijd gehad met jullie. Madeleen en Bianca, toen ik 
dacht dat mijn arbeidsethos wel in orde was leerde ik jullie kennen en kwam erachter 
dat ik helemaal niet zo hard werk. Jullie waren vaak zeven dagen per week dag en 
nacht met jullie onderzoek bezig, iets waar ik met verbazing naar keek. Gelukkig 
kwam ik jullie regelmatig tegen tijdens de spinsessies in Il Fiore, een teken dat 
jullie ook sportief op topniveau zaten. Ik heb veel respect voor jullie gedrevenheid 
waardoor jullie zeker gerenommeerde wetenschappers gaan worden. Madeleen, ik 
wens je veel plezier en succes in Stockholm, ontzettend gaaf dat je in deze hippe 
stad je carrière kunt vervolgen. Bianca, soms ook wel het muizenmeisje genoemd, 
je bent een doorzetter als geen ander, veel plezier en succes in de toekomst! Vanuit 
mijn basis op kamer 2.306 begon de werkdag meestal met een bakkie met de 
andere collega’s een paar kamers verderop. In de eerste kamer zaten Anouk, Mark, 
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Christel en later Lisje. Anouk, nadat je terug kwam uit Afrika ben je ook in de bruin 
vet hype terecht gekomen. De acclimatisatiestudie is tot nu toe de kroon op je werk 
en laat zien dat je enorm gedreven bent. Ik wil je bedanken als betrokken collega en 
voor je vermogen om mij weer met beide benen op de grond te zetten als ik weer 
eens iets te hooghartig werd. Mark, Hanssen, Handsome, jij was bij binnenkomst al 
een topper en weet zelf heel goed waar je mee bezig bent. Je bent een mooie vent 
(letterlijk en figuurlijk ;), bedankt voor de leuke tijd. Christel, Crystal, de koningin 
van de respiratiekamers, bedankt voor je Brabantse gezelligheid. Lisje, ook jij bent 
vanuit Eindhoven naar het Maastrichtse gekomen, ik wens je veel succes en wil je 
bedanken voor de leuke uitjes en mooie avondjes. In de volgende kamer heerste 
er een aparte sfeer die ik misschien wel nooit meer mee mag maken. Boris, Erik 
en Maarten, wat zijn jullie samen topgasten! Het was altijd een gekkenhuis bij 
jullie; balletje-balletje, hardcore-kwartiertje, Dumpert, altijd wat te doen en voor 
mij vaak een opkikker om uit de dagelijkse sleur te komen. Erik, Knallert, we hebben 
elkaar goed leren kennen en ik heb diep respect voor jouw authenticiteit. Je blijft 
altijd jezelf en wist je door een moeilijke periode te slepen. Een hoogtepunt was 
jullie bruiloft, ik hoop je nog vaak te zien en nog veel feestjes met je te mogen 
maken. Boris, B-to-the-K, zonder jouw hulp had ik dit proefschrift écht niet kunnen 
schrijven. Je hielp met veel geduld bij mijn berekeningen en was nooit te beroerd 
om mee te denken. Naast het werk zijn we goede vrienden geworden met mooie 
Julius Caeser en Stalin pokeravonden, casinoritjes, een ludieke zwemtocht naar het 
schateiland en een prachtige promotie. Ik waardeer je keus om je gevoel te volgen 
en de wetenschappelijke wereld even te ontspringen. Maarten, Vosje, sinds je 
aanstelling in november 2009 hebben we veel lol gehad. Op congressen waren we 
vaste kamergenoten, waarbij we in Stockholm en Istanbul vergezeld werden door 
onze goede vriend dr. Death; ‘don’t worry, we are doctors’. We hebben veel en 
intensief samen gewerkt, waarbij jij altijd rust en overzicht houdt en de juiste balans 
tussen werk en privé kent. Op maandag altijd even kijken of je de voorpagina van 
de Limburger weer gehaald hebt en een carrière als filmster in Allstars zijn maar een 
paar voorbeelden van de mooie tijd als collega’s. Samen waren we Boris’ paranimf 
en ik ben enorm blij dat je ook bij mij aan mijn zijde wilt staan, het belooft een 
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mooie dag te worden. Evie, jij bent mijn bench-to-bedside opvolger en werd direct 
op het zware thyroidproject geplaatst. Je bent een nuchtere, hardwerkende arts, ik 
wens je enorm veel plezier en succes met je promotietraject.
Op niveau 0 werd echt gewerkt en wil ik een aantal collega’s bijzonder bedanken. 
Esther Phielix, als oxygraafleerling wist je mij wegwijs te maken in het lab en later 
hebben we samen op internationaal niveau de - lange termijn - thyroidstudie op 
weten te zetten. Bedankt voor de introductie in de wetenschap. Tineke, onze 
samenwerking was altijd erg gemoedelijk en je ging zelf als een speer door je 
promotietraject. Je keus voor een huis over de grens en een zwangerschap 
kenmerken je en ik weet zeker dat op korte termijn hoogleraar radiologie bent. 
Lena en Silvie, jullie waren altijd in voor een praatje en een drankje, bedankt 
voor de gezelligheid. Lauren, thank you for guiding me through the extremely 
complicated process of developing our method te measure human BAT and WAT. 
I really enjoyed our time and wish you all the best in the States. Gert en Esther, 
bedankt voor jullie bereidwilligheid al dat vet- en spierweefsel te snijden, kleuren 
en op beeld vast te leggen. Joris en Johanna, jullie zijn een uniek Nederlands/
Zweeds paar en als collega’s hebben we prettig samen kunnen werken. Johanna, 
bedankt voor de eerste muizenmetingen en Joris bedankt voor al je hulp bij het 
analyseren en schrijven. Guy P., mijn naamgenoot en Bram, de Belgische charmeur, 
we hebben veel lol gehad tijdens de vrijmibo’s en daaropvolgende kroegavonden, 
waarvoor dank. Jos, zonder jou waren die borrels er nooit geweest. Ondanks het 
soms matige enthousiasme van anderen voor een biertje regelde jij altijd een goed 
gevulde koude kamer. Het was erg gezellig. Gijs Goossens, de tourpoolwinnaar en 
koffiedrabkijker, het was mooi.
Dames van het secretariaat, Desiree, Claudia en Yolanda, bedankt voor alle 
paaseitjes, scans en koffiepraat.
Loek, Paul en Laurens, bedankt voor de onvoorwaardelijke ondersteuning van alle 
gammele Omnicals en Oxycons.
Alle FDG-PET-CT scans om de vaak minimale hoeveelheden bruin vet in kaart te 
brengen waren onmogelijk geweest zonder de gastvrijheid en hulp die ik kreeg op 
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